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 Amyotrophic lateral sclerosis (ALS) is a debilitating disease that is characterized 
by late-onset, progressive neuronal degeneration of the motor neurons, which results in 
dysphagia, dyspnea, dysarthria and eventually death. There is currently no cure for ALS, 
with riluzole being the only FDA-approved drug that only extends survival by 3 to 6 
months without repairing the damaged motor neurons. Transgenic mice, especially the 
one with superoxide dismutase 1 glycine 93 to alanine mutation (SOD1-G93A), have 
been a mainstay in the study of ALS and its underlying pathophysiology, with more than 
3,000 articles upon a Pubmed search of (Amyotrophic Lateral Sclerosis OR ALS) AND 
(G93A OR Mouse). 
 Such a wealth of data allows for informatics approaches to understanding the 
pathophysiology of ALS. To form a framework for conducting an informatics study with 
primary journal articles about ALS, a nine-category ontology was created via a 
comprehensive, keyword-based agnostic survey of more than 1,300 journal articles, 
which is presented in Chapter 2. A meta-analysis of 45 journal articles was conducted to 
examine temporal relationships between calcium homeostasis, mitochondrial dysfunction 
and oxidative stress and to elucidate the timing of the disturbances, which is presented in 
Chapter 3. Chapter 4 thoroughly describes the biocuration process used for the projects in 
the laboratory and presents interesting findings about the associates in the laboratory. 
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using the SOD1-G93A model specifically cites 
‘G93A’ in the PubMed-searchable locations (i.e. 
title, abstract, etc.).
The SOD1-G93A mouse model has been uti-
lized to identify numerous deficits and impairments 
contributing to or the direct result of the mutation’s 
associated ALS pathophysiology. Briefly, such defi-
cits comprise the following: apoptosis, including 
changes in pro- and anti-apoptotic signals (4); axonal 
transport of mitochondria and other key cargoes (5); 
aberrant cellular chemistry such as reduced enzyme 
activity and metal mishandling (6); energetics, 
including disturbances of the physical and functional 
properties of mitochondria, ATP production and 
calcium homeostasis (7); genetic damage, including 
changes in mRNA or DNA; inflammation, including 
the migration of reactive astrocytes and microglia 
(8); oxidative stress, resulting from the build-up of 
free radicals (9); proteomics, characterized by the 
accumulation of misfolded SOD1 aggregates (10); 
Introduction
Amyotrophic lateral sclerosis (ALS) is characterized 
by progressive neurodegeneration of the motor neu-
rons, which leads to muscle paralysis, respiratory 
deficiency, and eventually death. Mutations of the 
superoxide (copper-zinc) dismutase-1 (SOD1) gene 
have been identified as contributors to familial ALS, 
which accounts for approximately 5–10% of all ALS 
cases (1). The SOD1-G93A (glycine 93 to alanine) 
mutation is a comparatively rare ALS mutation in 
humans, but it is the most studied and published 
mutation within experimental transgenic ALS mouse 
models (2,3). The SOD1-G93A transgenic ALS 
model’s popularity is largely due to its ALS symptom 
reproducibility and its widespread availability for 
purchase from The Jackson Laboratory (jaxmice.jax.
org). At the end of the 2014 year, searching for 
‘Amyotrophic Lateral Sclerosis’ AND ‘G93A’ in 
PubMed returned approximately 1300 articles, and 
the tally was actually greater since not every article 
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Abstract
Numerous sub-cellular through system-level disturbances have been identified in over 1300 articles examining the superox-
ide dismutase-1 guanine 93 to alanine (SOD1-G93A) transgenic mouse amyotrophic lateral sclerosis (ALS) pathophysiology. 
Manual assessment of such a broad literature base is daunting. We performed a comprehensive informatics-based systematic 
review or ‘field analysis’ to agnostically compute and map the current state of the field. Text mining of recaptured articles 
was used to quantify published data topic breadth and frequency. We constructed a nine-category pathophysiological function-
based ontology to systematically organize and quantify the field’s primary data. Results demonstrated that the distribution 
of primary research belonging to each category is: systemic measures an motor function, 59%; inflammation, 46%; cellular 
energetics, 37%; proteomics, 31%; neural excitability, 22%; apoptosis, 20%; oxidative stress, 18%; aberrant cellular chemis-
try, 14%; axonal transport, 10%. We constructed a SOD1-G93A field map that visually illustrates and categorizes the 85% 
most frequently assessed sub-topics. Finally, we present the literature-cited significance of frequently published terms and 
uncover thinly investigated areas. In conclusion, most articles individually examine at least two categories, which is indicative 
of the numerous underlying pathophysiological interrelationships. An essential future path is examination of cross-category 
pathophysiological interrelationships and their co-correspondence to homeostatic regulation and disease progression.

































2 R. B. Kim et al. 
systemic impairments, including overall system-level 
neuromuscular function and non-neuromuscular 
contributors (3). The phenotype severity and disease 
progression of the SOD1-G93A transgenic mouse is 
largely dependent upon the transgene copy number 
(typically denoted as ‘high’ versus ‘low’). The over-
whelming majority of SOD1-G93A transgenic mouse 
studies have used a high copy model, which has an 
average onset range of 85–100 days and endpoint of 
120–160 days (3).
Knowing the distribution and categorization of 
primary data is a key step towards both consolidating 
current knowledge and planning new research (11). 
However, with so many articles covering such an 
expansive and complex pathophysiology, it is diffi-
cult to manually determine what has and has not 
been examined in the SOD1-G93A transgenic ALS 
mouse field. Moreover, while traditional literature 
reviews help in digesting the details of published 
data, ideas, or mechanisms, their content does not 
necessarily quantitatively align with what actual pri-
mary data exist for a given topic or theorem. Authors 
of traditional literature reviews must subjectively 
determine what topics are reported based on the 
author’s exposure to the field. Automated informat-
ics-based systematic reviews or ‘field analyses’ over-
come the traditional limitations of manual literature 
reviews by comprehensively and agnostically search-
ing the primary data of every available article to 
quantify the breadth and depth of researched topics. 
The result is an objective map of the overall literature 
that structurally organizes and numerically identifies 
topical areas of prevalent data as well as disparate or 
thinly investigated areas where primary data are 
sparse.
Consequently, the goals of this informatics-based 
systematic review of the SOD1-G93A mouse model 
were to: 1) determine the published breadth and 
frequency of research topics; 2) systematically orga-
nize and categorize primary data articles using a 
pathophysiological function ontology; and 3) con-
solidate current knowledge and highlight corre-
sponding future research paths.
Materials and methods
The general method included finding SOD1-G93A 
articles; recapturing data from the article entities; 
devising and testing a term-category dictionary for 
identifying research terms/topics and for ontological 
categorization; searching the article entities to deter-
mine the frequency of primary data terms/research 
topics; assessment of the publication frequency 
and distribution within the pathophysiological onto-
logical categories.
Inclusion and exclusion criteria
To obtain the initial primary article selection pool, 
PubMed searches were conducted in October 2014 
to find all published articles with (‘Amyotrophic 
Lateral Sclerosis’ or ‘ALS’) in the title or abstract 
and (‘transgenic mouse’ or ‘G93A’) in the title or 
abstract. Initial primary article selection pool exclu-
sion criteria consisted of: non-English language 
articles; articles for which full-text pdf downloads 
were unavailable; and articles labeled as literature 
reviews. Articles were either downloaded using 
PubMed Central or from e-journal subscriptions 
available from the libraries of Georgia Institute of 
Technology and Emory University. Using these 
methods, less than 3% of the eligible initial article 
pool was unavailable for download. Based on these 
initial criteria, 1997 articles were eligible for inclu-
sion in the initial primary article selection pool.
To obtain the final article pool utilized to conduct 
this study, within-article keyword searches were per-
formed to find articles that contained ‘G93A’ in at 
least one of the following locations: article title, 
abstract, figure caption, or within the figure text (see 
Data recapture for details). The final article pool 
consisted of 1339 articles, all of which were included 
in the field analysis.
It should be noted that the overwhelming major-
ity of studies do not distinguish between strain and 
transgene copy number in the searchable article 
entities (and many articles do not mention them at 
all, even in the full-text methods). Thus, articles 
were not included or excluded based on transgene 
copy number (e.g. high, low) or strain (e.g. B6SJL, 
C57BL/6), i.e. our article pool represents a com-
bined assessment of research topics in the overall 
SOD1-G93A transgenic mouse field.
Data recapture
Data were recaptured from the following article 
locations, referred to as entities: article title, abstract, 
figure captions, and within figure text. ‘Within figure’ 
text included any text labeled on or within a figure 
or table, e.g. the x-y axis labels, bar graph categorical 
labels, legends, etc. Recaptured data were obtained 
from downloaded full-text pdf files. Abstract, title, 
and reference information was exported directly 
from PubMed. Figure captions and within figure 
text was manually scraped from the full-text pdf 
articles using a standard keyboard copy and paste 
command (12). Any special characters that did copy 
correctly were manually revised. A quality control 
team independently assessed all data recapture to 
ensure complete accuracy. Recaptured data were 
transcribed into a custom project-specific searchable 
relational database (www.pathology-dynamics.org). 
The database is implemented in Filemaker 13 Pro 
Advanced (Filemaker, Inc.).
Term-category dictionary
A dictionary of corresponding terms and categories 
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constructed that assigned frequent SOD1-G93A 
pathophysiology article terms and phrases to their 
most probable ontological category. The term- 
category dictionary allowed for automated searching 
of recaptured text and labeling of the articles entity’s 
and the overall article’s most probable ontological 
categories.
The chosen ontological categories were based on 
a previously published scheme (2) developed from a 
meta-analysis of SOD1-G93A traditional literature 
review articles. The ontology was used to categorize 
primary research data based on underlying 
pathophysiological function. The ontological catego-
ries consisted of: Apoptosis, Axonal Transport, 
Chemistry, Energetics, Excitability, Genetic Damage, 
Inflammation, Oxidative Stress, Proteomics and 
Systemic. The ontological categories are defined in 
detail in the Results and Discussion section.
To determine the most frequent keywords and 
phrases in the SOD1-G93A articles, word and phrase 
frequency analysis was performed using freely 
available software from WriteWords. Approximately 
6500 different terms and phrases were identified and 
sorted by their number of appearances in each 
recaptured entity and by their total number of 
appearances in the articles. Non-scientific words 
insignificant to the analysis (e.g. of, in, and, etc.) 
were immediately excluded. Subsequently, a group 
of trained researchers in SOD1-G93A pathophysiol-
ogy preliminarily labeled the most frequent 2000 
terms by their most likely ontological category.
After performing the first ontological test set 
search, some individual terms were combined to 
provide for better specificity (see details in Onto-
logical Test sets). Ultimately, 670 terms and phrases 
were selected for inclusion of the term-category 
dictionary (Supplementary Table I to be found 
online at http://informahealthcare.com/doi/abs/ 
10.3109/21678421.2015.1047455).
Field searches
Each keyword or phrase in the term-category dic-
tionary was searched in the recaptured data article 
entities (article title, abstract, figure caption, and 
within figure text). If the search keyword was a single 
word, a whole word search was performed. For a 
phrase, a whole word search was performed for each 
word but not necessarily in the order of the words, 
e.g. ‘copper concentration’ and ‘concentration of 
copper’ were detected upon searching for ‘copper 
concentration’. If the search was positive, the figure 
and article was labeled by the corresponding 
ontological category of that term. The categories 
identified in the figure caption and within figure text 
were combined to represent each individual figure’s 
ontological categorization. The categories identified 
in the article title, figure caption, and within figure 
text were combined to represent the overall catego-
rization of each article. It should be noted that the 
abstract was ultimately excluded from the overall 
article categorization due to the number of false-
positive hits it produced (see Test sets). Similarly, the 
ontological category, Genetic Damage, was individu-
ally excluded from the final field analysis results to 
decrease false-positives; corresponding articles were 
re-categorized according to the cited location of 
genetic damage (see Test sets).
Test sets
Test sets of SOD1-G93A figures and corresponding 
articles were constructed to determine which recap-
tured article entities should be searched and to 
evaluate the term-category dictionary. Each test set 
minimally consisted of 500–600 figures from 100 
different SOD1-G93A articles, which included pri-
mary data representing each ontological category. 
For the purpose of evaluating the term-category 
dictionary, the test set’s ontological categorization 
was separately and manually determined by inde-
pendent visual inspection of the article’s primary 
data by five trained SOD1-G93A pathophysiology 
researchers.
Evaluation included measures of sensitivity and 
specificity. Sensitivity (the ability of a test to identify 
a condition correctly) and specificity (the ability of 
a test to exclude a condition correctly) are often used 
to assess the capability of a search to produce accurate 
results. Sensitivity is defined as: number of true-
positives (TP) divided by the sum of the number of 
true-positives and false-negatives (FN): TP/ [TP  
FN]. Specificity is defined as the number of true- 
negatives divided by the sum of true-negatives and 
false-positives: TN/[TN  FP]. While having both a 
high sensitivity and specificity is ideal, realistically 
optimization is typically favored towards one or the 
other depending on the search/test outcome goal, i.e. 
whether it is more important that the search/test 
includes or excludes a condition. Given that our 
protocol searches multiple terms per entity and thus 
allows multiple categories to be assigned, specificity 
(the ability to exclude) was given greater priority in 
the test set design and assessment.
We assessed the article entities’ ability to cor-
rectly represent the primary data contained within 
the article. Searching the abstract text resulted in 
 50% false-positives, i.e. over 50% of the abstracts 
contained key terms or phrases that were either not 
represented/relevant to the article’s primary data or 
were not present in the article’s figure caption or 
within figure text. If the abstracts were to be used as 
part of the determination of the articles’ overall cat-
egorization, their false-positive terms would result in 
the addition of non-relevant categories. In contrast, 
searching the figure captions and within figure text 
resulted in  2% false-positives and article titles  4%. 
Therefore, as noted in field searches, the abstract 
search was excluded from the final ontological cat-

































4 R. B. Kim et al. 
Subsequently, we assessed the ability of each 
ontological category to represent the corresponding 
article’s primary data. All categories had greater than 
95% specificity with the exception of Genetic 
Damage. The category Genetic Damage consisted of 
many general terms (see Supplementary Table I to 
be found online at http://informahealthcare.com/ 
doi/abs/10.3109/21678421.2015.1047455), which 
resulted in low specificity ( 70%). Fortunately, 
genetic damage is typically measured in a specific 
location, organelle or pathway. Thus, articles 
containing primary data that examined genetic dam-
age were labeled with the category(ies) that corre-
sponded to the location or physiology affected by the 
genetic damage (e.g. mitochondrial mRNA damage 
→ Energetics).
Finally, an ontological test set was also utilized 
to assess the term-category dictionary itself. An 
initial test to identify false-positive and negatives 
resulted in 86.1% sensitivity and 79.0% specificity 
for articles and 81.5% sensitivity and 87.6% speci-
ficity for figures. Care was taken to increase specific-
ity by combining terms that created numerous 
false-positives into more specific phrases (e.g. aggre-
gation → protein aggregation). After correction, 
another test set was utilized to evaluate the final 
dictionary’s accuracy: 87.9% sensitivity and 99.9% 
specificity for papers and 77.9% sensitivity and 
97.5% specificity for figures. Given that specificity 
was the priority, an overall specificity  98% was 
considered acceptable for the study goals.
Results and discussion
We first present the field analysis results, including 
the overall distribution of research articles with pri-
mary data belonging to each of the nine ontological 
categories: Apoptosis, Axonal Transport, Chemistry, 
Energetics, Excitability, Inflammation, Oxidative 
Stress, Proteomics and Systemic. Subsequently, the 
quantitative topical distribution of research articles 
in each of the individual categories is presented and 
explained. Finally, we conclude with a discussion on 
categorical relationships and future directions.
Overall SOD1-G93A Field Analysis
We performed a field analysis based on key word 
searches of article titles, figure captions, and within 
figure text to examine the prevalence of the different 
types of pathophysiological research in the SOD1-
G93A ALS transgenic mouse model. The order of 
overall prevalence of primary data corresponding to 
the defined ontological categories of the SOD1-
G93A ALS published literature is as follows: 1) sys-
temic and functional measures, 59%; 2) inflammation, 
46%; 3) cellular energetics, 37%; 4) proteomics, 
31%; 5) excitability, 22%; 6) apoptosis, 20%; 7) oxi-
dative stress,18%; 8) aberrant cellular chemistry, 
14%; and 9) axonal transport, 10%. Figure 1 shows 
the distribution of articles across the nine categories 
as a percentage of the total SOD1-G93A articles 
along with their absolute article count.
All included primary articles and their figures 
were labeled with at least one category using the 
term-category dictionary. However, given the com-
plexity of the SOD1-G93A pathology, most articles 
actually belonged to more than one category. For 
example, a primarily proteomic study examining 
protein aggregation in conjunction with iron sulfur 
protein (ISP) belongs to both chemistry (due to 
‘iron’) and proteomics (due to ‘protein aggregation’). 
The average number of categories labeled for each 
article using the term-category dictionary search was 
2.6 with a standard deviation of  1.6. Multi-cate-
gory assignment to SOD1-G93A articles is, in large 
part, due to the numerous cross-category pathophys-
iological relationships (see Categorical relationships 
and future directions).
Figure 1. SOD1-G93A transgenic mouse model research 
categorized by article topic frequency based on a nine-category 
pathophysiological function ontology. For each category, the 
graph illustrates the absolute article count and percentage of 
the total SOD1-G93A articles with primary data based on word 
frequency searches of the title, figure captions, and within 
figure text. Articles are typically classified under two or three 
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The most common 12 terms of each category 
(with the variations ‘or’-merged into one search) 
accounted for the categorization of greater than 
85% of the articles in the category. Thus, these most 
prevalent 12 terms per category were used to develop 
the field analysis map shown in Figure 2. The field 
analysis map visually illustrates the proportion of 
the SOD1-G93A primary data encompassed by 
each overall category and also the most prevalent 
within category terms. The size of the boxes corre-
sponds to the approximate relative size of the 
categories or the categorical terms. In Table I we 
reveal the number of articles and figures/tables with 
primary data corresponding to each of the 12 most 
prevalent terms per category. The full term-category 
dictionary and field analysis assessment is shown in 
Supplementary Table I to be found online at http://
informahealthcare.com/doi/abs/10.3109/21678421.
2015.1047455.
Topical Analysis within Ontological Categories
We present the informatics results of the topical 
analysis performed within each of the ontological 
categories and provide brief explanations of the top-
ics’ significance to the SOD1-G93A transgenic 
mouse pathophysiology. Given the goals of this infor-
matics-based systematic review, the primary purpose 
of the following text is to quantify and expound upon 
the preponderance of articles and sub-topics included 
in each ontological category. For further in-depth 
discussion of mechanisms and published experimen-
tal study results, we refer the reader to the cited 
references or topic-specific traditional literature 
reviews.
Apoptosis. Apoptosis, representing 21% of the SOD1-
G93A transgenic ALS mouse literature, encompasses 
all programmed cell death signaling pathways. 
Apoptosis has multiple relationships with other 
ontological categories given that the ultimate 
endpoint of the ALS pathology is cell death.
Caspases, and in particular caspase 1, 3, and 9, 
are responsible for many of the signaling cascades 
(13) that initiate apoptosis and, as such, are the most 
represented term under this category (122 articles, 
45% of Apoptosis). Intracerebroventricular adminis-
tration of zvAD-fmk, a broad caspase inhibitor, has 
been shown to delay disease onset and mortality in 
SOD1 ALS mice (13). Other key signals include 
Bcl-2 (31 articles, 11% of Apoptosis), which has 
both pro- and anti-apoptotic mechanisms, and Bax 
(25 articles, 9% of Apoptosis), which is pro-apoptotic 
(4,14). Many studies have examined the neuropro-
tective effects of Bcl-2 and how, in abundance, it 
Figure 2. Field map of the most prevalent SOD1-G93A transgenic mouse research topics. The sizes of the boxes represent the relative 
term frequency. The map illustrates categorical terms required to encompass at least 85% of the articles classified to each of the nine 
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Table I. The 12 most common terms or phrases per category are presented with a description and the resultant number of articles 
(A) and figures (F). Note that the 12 terms provided more than 85% coverage in each category (see Test sets).
Axonal Transport A F Description/Significance
retrograde, retrogradely 44 96 The movement of dynein cargoes towards the cell body
neurite, neurites 38 53 A projection from the cell body, so an axon or dendrite.
dynein 20 84 The motor protein that is responsible for carrying cargoes retrogradely
microtubule, microtubules 17 38 Neural structure or “tracks” on which dynein and kinesin travel.
vesicle 17 38 Transport unit often carried by dynein and kinesin.
anterograde, anterogradely 16 40 The movement of kinesin cargoes from soma towards neuromuscular junction
Synaptosome(s) 11 52 A type of vesicle transported in the axon
axon terminal, projection 10 13 Catch-all terms for detecting axonal transport papers.
kinesin 7 15 The motor protein that is responsible for carrying cargoes anterogradely
loa 7 28 “Legs at Odd Angles” - mutation that affects dynein “legs” (25).
neurofilament* transport 5 16 Neural structure element carried via “slow” axonal transport.
wallerian 4 9 Wallerian Degeneration is the degeneration of an axon.
Chemistry A F Description/Significance
copper, Cu2 58 236 Used by SOD1
zinc, Zn2 53 216 Used by SOD1
metal, metals 35 92 Catch-all terms for detecting data discussing metals
luciferase 31 41 An oxidative enzyme used in assays
iron, Fe, Fe2 17 44 Involved in Fenton reaction, which produces hydroxyl radical
HO-1, Heme oxygenase 17 40 Enzyme that catalyzes the degradation of heme, producing iron
vitamin, B12 16 48 Tried as a treatment (32).
lithium 8 46 Tried as a treatment (33).
ferritin 8 14 Controls iron in a cell
NaHCO3 5 10 Used as a buffer in various experiments, particularly those assessing metalation
Salubrinal 4 11 Used to suppress SOD1 activity (89).
vPA 4 9 valproic acid. Tried as a treatment (34).
Energetics A F Description/Significance
mitochondrial, mitochondria, mito, 
mitochondrion,
194 773 Produce ATP, involved in cellular respiration & calcium homeostasis.
calcium, Ca2, Ca2, ca 100 238 Required for respiration, excitability, and muscle contraction.
Cox, complex Iv 80 135 Last enzyme in the respiratory electron transport chain
ATP, ADP, ATPase 74 129 Energy units made or used in cellular respiration
cytochrome, cytochrome c 69 141 Transfers electrons from complex III – Iv
phosphorylation 47 89 Process of adding a phosphate group to a protein, turning it “on” or “off”
metabolism, metabolic 43 80 General term encompassing energy harvesting
complex I 28 51 Element of the electron transport chain of mitochondrial respiration
glucose 25 45 Main “fuel” for cellular respiration
creatine 23 75 Increases the formation of ATP
succinate 23 35 Encompasses Succinate Dehydrogenase, aka complex II, role in respiration
depolarization 19 37 Measure of mitochondrial respiration
Excitability A F Description/Significance
Glutamate 108 401 Excess extracellular glutamate causes neuronal degeneration
GLT1, GLT-1, EAAT2, EAAT 56 188 Glutamate transporters; decreases observed in ALS patients and G93A mice
Na, Na 52 112 Required for action potential; ions enter cell upon activation of glutamate 
receptors
Excitotoxicity, excitatory, 48 137 Terms describing toxic over-excitation
AMPA 35 107 a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid- glutamate receptor 
mediating fast excitatory transmission
cmap, cmaps 35 53 Compound muscle action potential-summation of several action potentials over 
several muscle fibers in one area
riluzole 33 85 Sodium channel blocker; the only FDA-approved drug for ALS.
NMDA 27 43 N-methyl-D-aspartate- glutamate receptor mediating slow excitatory 
transmission
GABA 22 50 ϒ-Aminobutyric acid- chief inhibitory neurotransmitter in mammals
GluR*, GluR1, GluR2, GluR 20 60 Glutamate receptors: Down-regulation of GluR2 leads to excess Ca2  influx
glutamine 16 34 Neurologically inactive form - precursor - of glutamate
aspartate 16 32 Stimulates NMDA receptors, but not as strongly as glutamate does
Oxidative stress A F Description/Significance
H2O2, Hydrogen peroxide 69 129 Free radical. Relatively weak but can produce stronger oxidants.
oxide 47 154 Catch-all term for elements causing oxidation
ROS, reactive oxygen species 47 90 Reactive molecules containing oxygen. Source of free radicals.
GSH, glutathione 45 101 Antioxidant that prevents damage from free radicals.
nitric, nitric oxide 43 145 Also known as NO. Common type of free radical.
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nNOS, NOS 34 68 Produces NO upon stimulation by inflammatory cytokines
Peroxide, peroxides 26 44 Catch-all term for any peroxide. See hydrogen peroxide.
MDA 15 20 Marker for oxidative stress
Nrf2 15 73 Involved in antioxidant and anti-inflammatory defense (6).
GSSG 14 19 Oxidized form of glutathione
DMPO 11 27 Used in spin trapping to measure the levels of free radicals.
Inflammation A F Description/Significance
GFAP 245 399 Glial fibrillary acidic protein-an indicator of the progression of gliosis
astrocyte 233 579 Astroglia that support neural function; assist in scarring following neural 
damage
T-cells, T-cell, CD11b, CD4 181 331 Provides neuroprotection
microglia, microglial 172 406 Excess activation leads to neurodegeneration
glial cell, glia 106 247 Catch-all terms for various glial cells.
inflam*, neuroinflamm*, immune 79 285 Catch-all terms for neuroinflammatory processes.
TNF, TNF alpha, TNFalpha, 
TNFa, TNF a, tumor necrosis 
factor
66 129 Tumor necrosis factor a. Stimulates immune activation, leading to gliosis
IL, IL 6, IL 4, interleukin 56 78 Interleukins stimulate immune cell activation, leading to gliosis
macrophage, M2, M1 53 88 Regulate immune activity via production of cytokines
vEGF 44 124 vascular endothelial growth factor. Tried as a treatment (69)
cytokine, cytokines 38 82 Catch-all terms microglial priming and immune cell activation elements
LPS 33 56 Lipopolysaccharide- activates glial cells, inducing gliosis
Apoptosis A F Description/Significance
caspase 122 225 Key apoptotic signal
apoptosis, apoptotic 114 294 Programmed cell death
akt 43 81 When activated by vGEF possibly acts as an anti-apoptotic factor
Bcl 2 31 85 A protein involved in both pro and anti-apoptotic mechanisms
bax 25 43 A pro-apoptotic protein
fmk 19 27 Anti-apoptotic signaling pathway
p75NTR 17 44 p75 neurotrophin receptor promotes caspase-dependent axon degeneration
p53 17 38 Tumor-suppressing protein in apoptosis.
L-NAME 15 28 Reduces NO and reverts the pro-apoptotic factors of it
FASL 11 26 Fas ligand; induces apoptosis when bound to its receptor
MPTP 10 27 Neurotoxin that induces apoptosis
XIAP 9 15 X-linked inhibitor of apoptosis protein
Proteomics A F Description/Significance
Aggregate(s), aggregation, 168 575 Aggregates of mutant, misfolded proteins are a hallmark of ALS
ubiquitin 89 165 Affects protein degradation, trans-location, and interaction
Kinase(s) 65 193 Affects protein activity, signaling; implicated in protein aggregation  
in ALS
protein binding 58 109 Catch-all term for binding processes of mutant SOD1 leading to  
aggregation.
proteasome, proteasomal 54 143 Involved in protein degradation.
disulfide 35 131 Disulfide bonds mediate the aggregation process in SOD1
oligomer* 30 40 Catch-all term for proteins
heat shock protein, hsp 30 74 Response to proteomic stress. Up-regulation extends survival.
ER Stress 27 75 Endoplasmic reticulum stress from unfolded proteins
misfolded protein, protein fold 
change
27 43 The fold change (misfolded proteins) leads to protein aggregates.
protein degradation 24 36 Dysfunctional degradation of misfolded proteins causes aggregates
TDP-43, TDP 43 23 59 TAR-DNA binding protein 43. Inclusions commonly found in ALS  
patients.
Systemic A F Description/Significance
Density, count or activity of motor 
neurons (all spellings)
323 483 Includes functional measures of locomotor activity and assessment of motor 
neuron degeneration
rotarod, rotorod, rot*rod 217 267 Experimental device and test used to assess mouse motor function
disease progression 205 553 Catch-all term for in vivo observation of disease progression.
hindlimb, forelimb, limb, 173 318 Hindlimb tremors are commonly used as a marker of disease onset
body weight 171 233 Indicator of disease progression; decreases in later stages of the disease.
lifespan, life span 121 240 The total time spent alive for the subject.
cumulative survival 103 119 The endpoint of the disease. Total lifespan of subject.
probability of onset 102 109 The time when symptoms of ALS typically begin to appear.
grip, grip strength 94 134 Test assessing mouse’s ability to grip; indicator of motor function/progression
in vivo, invivo 88 209 “Within the living” - encompasses all experiments performed on live test 
subjects.
gastrocnemius 75 151 Large muscle found in the hindlimb, easy to access and evaluate.
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could be used to abolish the proapoptotic compo-
nent of Bax in SOD1-G93A mice (4,15).
P53 and p75NTR have been examined equally 
with 17 articles each, collectively representing 13% 
of the Apoptosis literature. An increased level of p53 
tumor protein is observed in ALS patients (16), but 
the absence of p53 does not affect the SOD1-G93A 
mice (17,18). p75NTR is a neurotrophin receptor 
that regulates signal cascades and functions of cells, 
and has been implicated in motor neuron degenera-
tion in ALS (19). Reduction of Fas ligands (FASL) 
was examined in 11 articles as a way to increase 
survival in ALS mice (20). MPTP, examined in 10 
articles, is a neurotoxin known to induce apoptosis 
that has been shown to increase SOD1 activity when 
administered to SOD1-G93A mice (21).
Axonal Transport. Comprising just 10% of the 
SOD1-G93A literature, axonal transport has been 
the least studied pathophysiological category. 
Molecular motors carry necessary constituents in 
the axon from the soma to the neuromuscular junc-
tion (i.e. anterograde transport via kinesin) and from 
the neuromuscular junction to the soma (i.e. retro-
grade transport via dynein) (22,23). Mutations to 
the machinery and cargoes can impair their attach-
ment to the motor proteins and their mobility (5). 
Notably, in SOD1-G93A transgenic ALS mice, 
axonal transport deficits appear well before cell 
degeneration occurs (24). In addition to possible 
transport-specific defects, axonal transport is thought 
to be further hindered due to inadequate mitochon-
drial ATP (see Energetics), an over-abundance of 
misfolded SOD protein aggregates (see Proteomics), 
and possible excitotoxic burdens (see Excitability).
Retrograde movement was the term that appeared 
most often in the axonal transport literature (44 
articles, 23% of Axonal Transport) with dynein rank-
ing third in frequency (20 articles, 14% of Axonal 
Transport). A mutation in dynein has been shown to 
rescue axonal transport defects and overall extend 
the lifespan of ALS SOD1-G93A mice (25). 
Comparatively, anterograde transport (16 articles, 
12% of Axonal Transport) by kinesin (seven articles, 
5% of Axonal Transport) does not appear as 
frequently in the SOD1-G93A literature despite 
both anterograde and retrograde transport deficits 
having been documented in SOD1-G93A mice (26).
Chemistry. The ontological category of chemistry, 
accounting for 14% of the SOD1-G93A literature, 
includes measures of aberrant cellular chemistry, 
enzymatics, catalytics and metal mishandling pres-
ent in the SOD1-G93A ALS pathophysiology (2). 
Copper and zinc collectively represent 39% of the 
chemistry literature, although their frequency is 
slightly over-represented due to their appearance in 
the name of ‘copper zinc superoxide dismutase-1’. 
Beyond their involvement in SOD1, copper and 
zinc concentrations have been measured in differ-
ent locations, with decreases shown in the liver and 
spinal cord (27). The effect of zinc supplementation 
in SOD1-G93A mice has been examined, including 
its increased affect on NMDA-mediated excitotox-
icity in SOD1, as well as its negligible impact on 
survival (28).
Another frequent cellular chemistry assessment 
is iron homeostasis, which represents 9% of the 
chemistry literature. Iron homeostasis has been 
shown to be impaired in both SOD1-G93A trans-
genic mice and in human ALS patients (29). An 
increase in iron content and iron genes expression 
has been observed in G93A-SOD1-transfected 
neuroblastoma cells compared to wild-type coun-
terparts (6). Iron could also be contributing to the 
disease via the Fenton reaction, which accelerates 
hydroxyl radical production that damages cellular 
DNA (30).
Heme oxygenase-1 (HO-1), representing 9% of 
the chemistry literature, is an enzyme that assists in 
degrading heme, and has been observed to increase as 
ALS progresses (31). vitamins (32), lithium (33) and 
valproic acid (vPA) have been explored (34) as treat-
ment options but have shown negligible success.
Energetics. Energetics, which encompasses mitochon-
drial production of ATP via cellular respiration, is 
the third most represented ontological category, 
encompassing 39% of the SOD1-G93A transgenic 
mouse literature. Understandably, mitochondria and 
variations of this word are the most represented 
terms, encompassing 39% of the Energetics category 
itself. As ALS progresses, mitochondrial ability to 
produce ATP decreases (35), which leads to axonal 
transport deficiencies, axonal retraction, denerva-
tion, and death of cells via apoptosis (36). SOD1-
G93A mice mitochondria change in both physical 
appearance and chemical functionality as the disease 
progresses (37).
Calcium, the second most prevalent Energetics 
term, represents 20% of the Energetics ontological 
category. Calcium overload, a known issue in SOD1-
G93A mice, leads to cell death via increased mem-
brane permeability and loss of ATP production. 
Overexpression of Ca2 binding proteins such as 
parvalbumin (38) and calbindin D28K (38,39) have 
been shown to improve disease parameters. Interest-
ingly, most articles examining calcium homeostasis 
utilize in vitro assessments (40), although in vivo 
examination is increasing (41). Finally, it should be 
noted that while calcium is listed in Energetics 
because the majority of articles examining it investi-
gate calcium handling by mitochondria (42), there 
are also other aspects of calcium that are clearly 
related to excitability due to its role in neural trans-
mission and axonal transport (41).
Glucose and related cellular pathway machinery 
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keywords in the Energetics category, as shown in 
Table I. Specifically, glucose utilization rates are 
impaired in SOD1-G93A mice in as early as 60 days 
(43). GAPDH, an enzyme important for the break-
down of glucose for energy, as well as creatine, have 
also been found to decrease by approximately 40% 
in SOD1-G93A mouse models (44). Creatine treat-
ment has been shown to protect against excitotoxic 
lesions created by NMDA (45) and MPTP, which 
interferes with complex I, slowing mitochondrial 
metabolism. Finally, complex I, pyruvate, and cyto-
chrome C have all have shown some forms of defi-
ciency in SOD1-G93A mice (35).
Excitability. Excitability is ontologically defined as 
the physiological pathways involved in producing 
action potentials. Excitability is an integral aspect of 
the ALS pathophysiology, representing 23% of the 
SOD1-G93A transgenic mouse literature. More spe-
cifically, excitability encompasses excitotoxicity, the 
pathological toxic over-excitation of neurons that is 
thought to contribute to the neuronal degeneration 
seen in SOD1-G93A ALS mice (46). However, there 
has been recent debate as to whether SOD1-G93A 
mice experience hyperexcitability (47), hypoexcit-
ability (48) or a combination of both that changes 
with temporal disease progression (2).
Over-excitation due to glutamate homeostasis is 
the most frequently cited excitotoxic contributor 
(160  articles, 54% of Excitability). Most of the 
SOD1-G93A specific research has focused on gluta-
mate uptake, concentrations of glutamate in various 
locations and their effects on the systemic progres-
sion of the disease. Since overstimulation is caused 
by the influx of sodium (56 articles, 18% of Excit-
ability) and calcium ions, various treatments have 
been tried to inhibit the voltage-gated sodium and 
calcium channels. Riluzole (12% of Excitability lit-
erature), one of the most common treatments for 
clinical ALS, is thought to work by inactivating the 
voltage dependent sodium receptors (49,50) on the 
glutamatergic nerve terminals (46,51).
The two main receptors of glutamate, calcium-
permeable AMPA (a-amino-3-hydroxy-5-methyl- 
4-isoxazole propionic acid) and NMDA 
(N-methyl-D-aspartate), are also researched heavily 
with the SOD1-G93A model and collectively repre-
sent 21% of the SOD1-G93A Excitability literature. 
AMPA receptors lacking GluR2 expression have 
high calcium permeability and are therefore more 
susceptible to motor neuron death from excitotoxic-
ity (51). Loss, decrease or immunoreactivity of 
glutamate transporters (56 articles, 19% of Excit-
ability), including EAAT2 (excitatory amino acid 
transporter-2) (52), all of which have been shown in 
SOD1-G93A mice, may also give rise to selective 
motor neuron degeneration.
GABA, another frequent topic in the excitability 
literature (7% of Excitability), is a neurotransmitter 
responsible for regulating excitability. Related topics 
frequently examined include GABA’s current density 
and amplitude (53), concentration (54), release and 
transmission upon treatments, by itself (55), or with 
glycine (56), methionine sulfoximine (MSO) (57), 
ionomycin (58), and HU210 (59).
Besides glutamate and its related measures, the 
Compound Muscle Action Potential (CMAP) is 
the next most frequently investigated measure of 
excitability (35 articles, 12% of Excitability). While 
modest at first, it has been observed that CMAP 
amplitudes drastically decrease in the final weeks 
before death (60).
In perhaps surprising contrast, other forms of 
SOD1-G93A traditional electrophysiological prop-
erties of motor neurons were not in the top 12 or 
upper 85% of Excitability terms. However, a sector 
of research is ongoing with, for example, persistent 
inward currents or PICs (50,61), frequency-current 
or F-I gain (48,62), and dendritic processing (63), 
to name just a few examples.
Inflammation. One of the fundamental characteris-
tics in progression of ALS is activation of microglia 
and astrocytes, a process referred to as neuroinflam-
mation. Inflammation is the second-largest SOD1-
G93A pathophysiological category as nearly half of 
the papers were identified as discussing some aspect 
of neuroinflammation. An in-depth ontological map 
of this category is shown in Figure 3. A major goal 
of inflammation research is to determine which 
parameters are expediting the disease versus which 
ones are protecting against it.
The degree of gliosis, scarring caused by reactive 
astrocytes, is a major indication of ALS progression 
in SOD1-G93A mice (64), as such reactive inflam-
matory cells are thought to contribute to death of 
the motor neurons (MNs). Not surprisingly, nearly 
half of the most prevalent inflammation key terms is 
related to some aspect of gliosis. Gliosis is often 
assessed using GFAP expression (64), which is also 
the most prevalent key word in the inflammation 
literature (240  articles, 39% of Inflammation).
Microglial activation was the second-most 
assessed inflammatory topic (28% of Inflammation). 
In particular, common direct measures encompassed 
cytokines, including iNOS, TNF-alpha, and various 
interleukins (IL). An increased level of TNF-alpha 
(11% of Inflammation) has been observed in human 
ALS patients, but the absence of TNF-alpha in 
SOD1-G93A mice did not affect the survival (65). 
Nonetheless, lowering the activity of other cytokines, 
such as IL-1beta, has been shown to reduce inflam-
mation and extend survival in SOD1-G93A mice 
(66). Additionally, macrophage activation (9% of 
Inflammation), which results in the production of 
cytokines, has been investigated in SOD1-G93A 
mice and in clinical patients, where an up-regulation 
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migration of microglia and macrophages is often 
used to evaluate the effectiveness of anti-inflamma-
tory treatments (67).
vascular endothelial growth factor (vEGF), 
which has been investigated in 44 articles (7% of 
Inflammation), plays a role in neuronal protection 
from ischemic and hypoxic damages (68), and, 
used as a treatment, has shown promising results 
in both SOD1-G93A mice and in humans (69). 
Although vEGF has been classified under Inflam-
mation due to its protective effects on neuroin-
flammation, studies suggest it may also act to 
reduce excitotoxicity and downstream apoptotic 
pathways (68).
Oxidative Stress. Oxidative stress, representing 19% 
of the SOD1-G93A literature, reflects an imbalance 
between the systemic manifestation of reactive 
oxygen species and the normal physiological ability 
to readily detoxify the reactive intermediates or to 
repair the resulting damage (30). Disturbances in 
the normal redox state of cells, such as those in 
SOD1-G93A transgenic mice, can cause toxic 
effects through the production of peroxides and 
free radicals. Resulting damage can affect many 
components of the neural and glial cells, including 
proteins, lipids, and DNA (9). Furthermore, some 
reactive oxidative species act as cellular messengers 
in redox signaling. Thus, oxidative stress can 
interfere with normal mechanisms of cellular sig-
naling, and so many oxidative stress articles also 
examine their effects on other ontological categories, 
including excitability, inflammation and systemic 
outcomes.
Peroxides, and specifically hydrogen peroxide 
(H2O2), represent 29% of the SOD1-G93A oxida-
tive stress literature. Peroxides are produced during 
the electron leakage from mitochondria (9). Thus, 
most such articles focus on reducing the effects of 
peroxides produced by damaged mitochondria 
(70,71).
Other free radicals and oxidants for which the 
effects of various treatments have been investigated 
include nitric oxide (NO-) (72) and peroxynitrite 
(ONOO-) (73). Transcription factor Nrf2 (6% 
of Oxidative stress) is known to interact with the 
antioxidant-response element enhancer sequence to 
increase protein expression involved in antioxidant 
defense (74). In the SOD1-G93A model, a signifi-
cant decrease has been cited in the expressions of 
antioxidant response genes regulated by Nrf2 (75) 
and the effects of the Nrf2/ARE system activation 
(76). Other highly cited antioxidants include gluta-
thione and peroxidase, which were found in over 
75  SOD1-G93A articles (33% of Oxidative stress).
Proteomics. The cellular stress caused by aggregates 
of mutant, misfolded proteins is a hallmark of 
neurodegenerative diseases including ALS (36). The 
misfolded and aggregated proteins are considered 
to play a lead role in the pathophysiology of the 
SOD1-G93A transgenic ALS mouse. Hence, the 
majority of papers in proteomics, 168 or 40% of all 
proteomics-labeled articles, were concerned with 
aggregation. Mutant SOD1 seems to impair the 
proteasomal pathway and autophagy of the cell’s 
degradation machinery (36). Thus, instead of under-
going degradation, these misfolded proteins begin to 
aggregate in the cell. Like the amyloid tangles in 
Alzheimer’s disease, a major question of the pro-
teomics field has been whether these misfolded 
aggregates are a cause of the ALS pathology, in and 
of themselves, or if they are simply a pathological 
side-effect (77).
Figure 3. Field map of the inflammation categories based on 
their pathophysiological properties and significance to 
demonstrate the variety of terms that were searched. The 
frequency search reveals that a few measures are used for 
specific cell types, e.g. GFAP expression was much more heavily 
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Misfolded protein degradation is dependent on 
proteasomes (54 papers, 13% of Proteomics), which 
have been shown to be impaired in SOD1-G93A 
mice (78). The two most common proteasomes 
studied are LMP2 and LMP7, mentioned by eight 
and six papers, respectively (Supplementary Table I 
to be found online at http://informahealthcare.com/
doi/abs/10.3109/21678421.2015.1047455). Ubiquitin 
(89 articles, 21% of Proteomics) labels proteins for 
degradation, and has also been shown to be inap-
propriately included in aggregates (10).
Many patients with ALS show inclusions con-
taining ubiquitinated and phosphorylated TAR-DNA 
binding protein 43 (36). Most of the articles, 23 in 
total, examined the amount of TDP-43 as a measure 
of proteomic progression in SOD1-G93A ALS mice. 
Additional stress factors resulting from protein 
aggregation, such as overexpression of various heat 
shock proteins (HSP) and ER stress (54 articles, 
13% of Proteomics), are increased in SOD1-G93A 
mice and are thought to coincide with disease 
progression (79). The effect of disulfide-linking at 
cysteine sites has been shown to slow the rate of 
mutant SOD1 degradation (80) and subsequently 
increase aggregation (81).
Systemic. The systemic category includes measures 
that examine the disease on a higher physiological 
scale including overall tissue death, functional 
outcomes, and other possible contributors of non-
neuromuscular origin. Additionally, disease onset 
and endpoint measures are contained within the sys-
temic category. Systemic evaluations are important 
to SOD1-G93A research because they demonstrate 
the point at which the pathology is impacting overall 
function and/or health. Thus, it is not surprising that 
the systemic category is the most frequently assessed 
SOD1-G93A ontological category (see Figure 1). 
Many articles utilize systemic measures to assess 
their possible relationship to primary experimental 
measures from other ontological categories.
Rotarod performance (a motor function test 
where the mouse is placed on a rod rotating at either 
a constant or accelerating speed and time is mea-
sured until the animal falls), grip strength, and grip 
endurance, are all in vivo physical motor function 
tests that are utilized to assess neuromuscular dis-
ease progression in transgenic SOD1-G93A ALS 
mice (3). Collectively, these functional measures 
account for approximately 28% of the systemic cat-
egory.
Neuronal density and overall motor neuron 
count, which are known to continuously decrease 
with SOD1-G93A ALS mouse disease progression, 
are the most prevalent measures of the systemic 
category, encompassing 41% of the systemic litera-
ture. Unlike the functional measures, they can be 
measured in either in vivo or in vitro experimental 
settings.
Systemic measures are also used to assess the 
disease onset and endpoint in in vivo experiments 
with SOD1-G93A transgenic ALS mice. Measures 
of onset appear in greater than 98% of articles 
assigned to the systemic category. Onset is typically 
defined by the start of a wobbly gait, hindlimb 
clasping, or a percent drop in rotarod performance 
(82). The endpoint is typically defined as either full 
limb paralysis, failure to stand on a rotating rotarod, 
or death (3,79).
The least represented sector of the systemic 
category is articles examining potential disease 
contributors of non-neuromuscular origin. Only a 
handful of articles were found. Examples include the 
role of possible liver disease (83) and T-lymphocytes 
(84). More research is needed in this non-neuromus-
cular sector given recent clinical findings citing the 
high relevance and relationships to overall health 
and/or other antecedent disease (85).
Categorical relationships and future directions
ALS has long been considered a multi-factorial 
disease (86). This characterization is supported by 
the many biological and pathological connections 
between the different presented ontological catego-
ries of the SOD1-G93A ALS pathophysiology. 
Hence, it is not surprising that each primary data 
article is typically represented by 2–3 different 
ontological categories. For instance, excitability 
(electrophysiology, channels, neurotransmitters, etc.) 
cannot be adequately studied without considering 
its strong ties to energetics (ATP, mitochondrial 
calcium homeostasis, etc.) and axonal transport 
(transport of mitochondria and neurotransmitters, 
etc.). A further complication of such pathophysio-
logical relationships is that they do not necessarily 
have the same sign or direction for the entire disease 
duration. For example, axonal transport appears to 
initially increase, possibly as a compensatory mecha-
nism, prior to later showing deficits (2,5,87). Exper-
imental measurement of relationships, especially 
temporal cross-category relationships (e.g. relation-
ship of excitotoxicity to energetics) is difficult due 
to the required longitudinal and combinatorial 
experimental design (2,88)
Temporal relationships in the high-copy mouse 
model have already been shown to drastically impact 
the overall dynamics of the SOD1-G93A ALS 
pathophysiology (2,48). Recent clinical ALS evidence 
has suggested possible neuroprotective effects related 
to pre-onset homeostatic regulation and possibly 
even hypervigilant regulation (85). Additionally, 
theoretical analysis has shown that treatments 
which address underlying system-level mathemati-
cal regulatory instabilities, including homeostatic 
oscillations, are more promising than traditional 
single-mechanism strategies (2,23). Collectively, 
current evidence indicates that future experimental 
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cross-category SOD1-G93A pathophysiological tem-
poral relationships is needed to help solve the many 
remaining mysteries.
Acknowledgements
Grants were received from the USA National 
Institute of Health (NS081426 and NS069616) to 
CSM.
Declaration of interest: The authors declare no 
conflict of interest with this manuscript.
References
Kiernan MC, vucic S, Cheah BC, Turner MR, Eisen A, 1. 
Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 
2011;377:942–55.
Mitchell CS, Lee RH. Dynamic meta-analysis as a therapeu-2. 
tic prediction tool for amyotrophic lateral sclerosis. 
Amyotrophic Lateral Sclerosis InTech. 2012. InTech. 




Pfohl SR, Halicek MT, Mitchell CS. Characterization of 3. 
the Contribution of Genetic Background and Gender to 
Disease Progression in the SOD1-G93A Mouse Model 
of Amyotrophic Lateral Sclerosis: A Meta-Analysis. J 
Neuromuscul Dis. 2015;10.3233/JND-140068
Gonzalez de Aguilar JL, Gordon JW, Rene F, de Tapia M, 4. 
Lutz-Bucher B, Gaiddon C, et al. Alteration of the Bcl-x/Bax 
ratio in a transgenic mouse model of amyotrophic lateral 
sclerosis: evidence for the implication of the p53 signaling 
pathway. Neurobiol Dis. 2000;7:406–15.
Mitchell CS, Lee RH. Cargo distributions differentiate 5. 
pathological axonal transport impairments. J Theor Biol. 
2012;300:277–91.
Hadzhieva M, Kirches E, Wilisch-Neumann A, Pachow D, 6. 
Wallesch M, Schoenfeld P, et al. Dysregulation of iron 
protein expression in the G93A model of amyotrophic lateral 
sclerosis. Neuroscience. 2013;230:94–101.
Shi P, Gal J, Kwinter DM, Liu X, Zhu H. Mitochondrial 7. 
dysfunction in amyotrophic lateral sclerosis. Biochim Biophys 
Acta. 2010;1802:45–51.
Philips T, Robberecht W. Neuroinflammation in amyotrophic 8. 
lateral sclerosis: role of glial activation in motor neuron 
disease. Lancet Neurol. 2011;10:253–63.
Barber SC, Shaw PJ. Oxidative stress in ALS: key role in 9. 
motor neuron injury and therapeutic target. Free Radic Biol 
Med. 2010;48:629–41.
Stieber A, Gonatas JO, Gonatas NK. Aggregation of ubiquitin 10. 
and a mutant ALS-linked SOD1 protein correlate with dis-
ease progression and fragmentation of the Golgi apparatus. 
J Neurol Sci. 2000;173:53–62.
Gupta A, Ludascher B, Grethe JS, Martone ME. Towards a 11. 
formalization of disease-specific ontologies for neuroinfor-
matics. Neural Netw. 2003;16:1277–92.
Mitchell CS, Halicek M, Kim R, Tilva K, Lee RH. Analysis 12. 
of ALS transgenic mouse research I:  1622 papers and 
counting…. Society for Neuroscience; San Diego, CA2013.
Li M, Ona vO, Guegan C, Chen M, Jackson-Lewis v, 13. 
Andrews LJ, et al. Functional role of caspase-1 and caspase-3 
in an ALS transgenic mouse model. Science. 2000;288: 
335–9.
vukosavic S, Dubois-Dauphin M, Romero N, Przedborski S. 14. 
Bax and Bcl-2 interaction in a transgenic mouse model of 
familial amyotrophic lateral sclerosis. J Neurochem. 1999; 
73:2460–8.
Gould TW, Buss RR, vinsant S, Prevette D, Sun W, 15. 
Knudson CM, et al. Complete dissociation of motor neuron 
death from motor dysfunction by Bax deletion in a mouse 
model of ALS. J Neurosci. 2006;26:8774–86.
Barbosa LF, Cerqueira FM, Macedo AF, Garcia CC, 16. 
Angeli JP, Schumacher RI, et al. Increased SOD1 association 
with chromatin, DNA damage, p53 activation, and apopto-
sis in a cellular model of SOD1-linked ALS. Biochim Biophys 
Acta. 2010;1802:462–71.
Kuntz Ct, Kinoshita Y, Beal MF, Donehower LA, 17. 
Morrison RS. Absence of p53: no effect in a transgenic 
mouse model of familial amyotrophic lateral sclerosis. Exp 
Neurol. 2000;165:184–90.
Prudlo J, Koenig J, Graser J, Burckhardt E, Mestres P, 18. 
Menger M, et al. Motor neuron cell death in a mouse model 
of FALS is not mediated by the p53 cell survival regulator. 
Brain Res. 2000;879:183–7.
Turner BJ, Murray SS, Piccenna LG, Lopes EC, Kilpatrick TJ, 19. 
Cheema SS. Effect of p75 neurotrophin receptor antagonist 
on disease progression in transgenic amyotrophic lateral 
sclerosis mice. J Neurosci Res. 2004;78:193–9.
Petri S, Kiaei M, Wille E, Calingasan NY, Flint Beal M. Loss 20. 
of Fas ligand-function improves survival in G93A-transgenic 
ALS mice. J Neurol Sci. 2006;251:44–9.
Fornai F, Carri MT, Ferri A, Paolucci E, Prisco S, Bernardi G, 21. 
et al. Resistance to striatal dopamine depletion induced 
by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice 
expressing human mutant Cu/Zn superoxide dismutase. 
Neurosci Lett. 2002;325:124–8.
Lee RH, Mitchell CS. Axonal transport cargo motor count 22. 
versus average transport velocity: is fast versus slow transport 
really single versus multiple motor transport? J Theor Biol. 
2015;370:39–44.
Mitchell CS, Lee RH. A quantitative examination of the role 23. 
of cargo-exerted forces in axonal transport. J Theor Biol. 
2009;257:430–7.
Williamson TL, Cleveland DW. Slowing of axonal transport 24. 
is a very early event in the toxicity of ALS-linked SOD1 
mutants to motor neurons. Nat Neurosci. 1999;2:50–6.
Kieran D, Hafezparast M, Bohnert S, Dick JR, Martin J, 25. 
Schiavo G, et al. A mutation in dynein rescues axonal trans-
port defects and extends the life span of ALS mice. J Cell 
Biol. 2005;169:561–7.
Kuzma-Kozakiewicz M, Kazmierczak B, Usarek E, 26. 
Baranczyk-Kuzma A. Changes in kinesin expression in the 
CNS of mice with dynein heavy chain 1 mutation. Acta 
Biochim Pol. 2013;60:51–5.
Lelie HL, Liba A, Bourassa MW, Chattopadhyay M, 27. 
Chan PK, Gralla EB, et al. Copper and zinc metallation 
status of copper-zinc superoxide dismutase from amyo-
trophic lateral sclerosis transgenic mice. J Biol Chem. 2011; 
286:2795–806.
Nutini M, Frazzini v, Marini C, Spalloni A, Sensi SL, 28. 
Longone P. Zinc pre-treatment enhances NMDAR-mediated 
excitotoxicity in cultured cortical neurons from SOD1-
G93A mouse, a model of amyotrophic lateral sclerosis. 
Neuropharmacology. 2011;60:1200–8.
Capitanio D, vasso M, Ratti A, Grignaschi G, volta M, 29. 
Moriggi M, et al. Molecular signatures of amyotrophic 
lateral sclerosis disease progression in hind and forelimb 
muscles of an SOD1-G93A mouse model. Antioxid Redox 
Signal. 2012;17:1333–50.
Barber SC, Mead RJ, Shaw PJ. Oxidative stress in ALS: a 30. 
mechanism of neurodegeneration and a therapeutic target. 
Biochim Biophys Acta. 2006;1762:1051–67.
Guo Y, Duan W, Li Z, Huang J, Yin Y, Zhang K, et al. 31. 
Decreased GLT-1 and increased SOD1 and HO-1 expression 
in astrocytes contribute to lumbar spinal cord vulnerability 
of SOD1-G93A transgenic mice. FEBS Lett. 2010;584: 
1615–22.
Gianforcaro A, Solomon JA, Hamadeh MJ. vitamin D(3) at 32. 

































 Informatics of SOD1-G93A ALS field   13
disease outcomes, in the G93A mouse model of ALS, and 
is toxic in females. PLoS One. 2013;8:e30243.
Ferrucci M, Spalloni A, Bartalucci A, Cantafora E, Fulceri F, 33. 
Nutini M, et al. A systematic study of brainstem motor 
nuclei in a mouse model of ALS, the effects of lithium. 
Neurobiol Dis. 2010;37:370–83.
Sugai F, Yamamoto Y, Miyaguchi K, Zhou Z, Sumi H, 34. 
Hamasaki T, et al. Benefit of valproic acid in suppressing 
disease progression of ALS model mice. Eur J Neurosci. 
2004;20:3179–83.
Kirkinezos IG, Bacman SR, Hernandez D, Oca-Cossio J, 35. 
Arias LJ, Perez-Pinzon MA, et al. Cytochrome c association 
with the inner mitochondrial membrane is impaired in the 
CNS of G93A-SOD1 mice. J Neurosci. 2005;25:164–72.
Robberecht W, Philips T. The changing scene of amyotrophic 36. 
lateral sclerosis. Nat Rev Neurosci. 2013;14:248–64.
Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, 37. 
Jenkins NA, et al. An adverse property of a familial 
ALS-linked SOD1 mutation causes motor neuron disease 
characterized by vacuolar degeneration of mitochondria. 
Neuron. 1995;14:1105–16.
Sasaki S, Warita H, Komori T, Murakami T, Abe K, Iwata M. 38. 
Parvalbumin and calbindin D-28k immunoreactivity in 
transgenic mice with a G93A mutant SOD1 gene. Brain Res. 
2006;1083:196–203.
Roy J, Minotti S, Dong L, Figlewicz DA, Durham HD. 39. 
Glutamate potentiates the toxicity of mutant Cu/Zn super-
oxide dismutase in motor neurons by postsynaptic calcium-
dependent mechanisms. J Neurosci. 1998;18:9673–84.
Jaiswal MK, Keller BU. Cu/Zn superoxide dismutase typical 40. 
for familial amyotrophic lateral sclerosis increases the 
vulnerability of mitochondria and perturbs Ca2 homeosta-
sis in SOD1-G93A mice. Mol Pharmacol. 2009;75: 
478–89.
Grosskreutz J, van den Bosch L, Keller BU. Calcium 41. 
dysregulation in amyotrophic lateral sclerosis. Cell Calcium. 
2010;47:165–74.
Kawamata H, Manfredi G. Mitochondrial dysfunction and 42. 
intracellular calcium dysregulation in ALS. Mech Ageing 
Dev. 2010;131:517–26.
Browne SE, Yang L, DiMauro JP, Fuller SW, Licata SC, 43. 
Beal MF. Bioenergetic abnormalities in discrete cerebral 
motor pathways presage spinal cord pathology in the 
G93A-SOD1 mouse model of ALS. Neurobiol Dis. 2006; 
22:599–610.
Pierce A, Mirzaei H, Muller F, De Waal E, Taylor AB, 44. 
Leonard S, et al. GAPDH is conformationally and function-
ally altered in association with oxidative stress in mouse 
models of amyotrophic lateral sclerosis. J Mol Biol. 2008; 
382:1195–210.
Beal MF. Neuroprotective effects of creatine. Amino Acids. 45. 
2011;40:1305–13.
van den Bosch L, van Damme P, Bogaert E, Robberecht W. 46. 
The role of excitotoxicity in the pathogenesis of amyo-
trophic lateral sclerosis. Biochim Biophys Acta. 2006;1762: 
1068–82.
Pambo-Pambo A, Durand J, Gueritaud JP. Early excitability 47. 
changes in lumbar motoneurons of transgenic SOD1-G85R 
and SOD1-G(93A-Low) mice. J Neurophysiol. 2009;102: 
3627–42.
Delestree N, Manuel M, Iglesias C, Elbasiouny SM, 48. 
Heckman CJ, Zytnicki D. Adult spinal motor neurons are 
not hyperexcitable in a mouse model of inherited amyo-
trophic lateral sclerosis. J Physiol. 2014;592:1687–703.
Kuo JJ, Lee RH, Zhang L, Heckman CJ. Essential role of 49. 
the persistent sodium current in spike initiation during 
slowly rising inputs in mouse spinal neurons. J Physiol. 
2006;574:819–34.
Kuo JJ, Siddique T, Fu R, Heckman CJ. Increased persistent 50. 
Na() current and its effect on excitability in motor neurons 
cultured from mutant SOD1 mice. J Physiol. 2005;563: 
843–54.
van Damme P, Dewil M, Robberecht W, van den Bosch L. 51. 
Excitotoxicity and amyotrophic lateral sclerosis. Neurodege-
ner Dis. 2005;2:147–59.
Warita H, Manabe Y, Murakami T, Shiote M, Shiro Y, 52. 
Hayashi T, et al. Tardive decrease of astrocytic glutamate 
transporter protein in transgenic mice with ALS-linked 
mutant SOD1. Neurol Res. 2002;24:577–81.
Carunchio I, Mollinari C, Pieri M, Merlo D, Zona C. 53. 
GAB(A) receptors present higher affinity and modified 
subunit composition in spinal motor neurons from a genetic 
model of amyotrophic lateral sclerosis. Eur J Neurosci. 
2008;28:1275–85.
Niessen HG, Debska-vielhaber G, Sander K, Angenstein F, 54. 
Ludolph AC, Hilfert L, et al. Metabolic progression markers 
of neurodegeneration in the transgenic G93A-SOD1 mouse 
model of amyotrophic lateral sclerosis. Eur J Neurosci. 
2007;25:1669–77.
Milanese M, Zappettini S, Jacchetti E, Bonifacino T, 55. 
Cervetto C, Usai C, et al. In vitro activation of GAT1 
transporters expressed in spinal cord gliosomes stimulates 
glutamate release that is abnormally elevated in the SOD1-
G93A() mouse model of amyotrophic lateral sclerosis. 
J Neurochem. 2010;113:489–501.
Raiteri L, Stigliani S, Zappettini S, Mercuri NB, Raiteri M, 56. 
Bonanno G. Excessive and precocious glutamate release in 
a mouse model of amyotrophic lateral sclerosis. Neurophar-
macology. 2004;46:782–92.
Ghoddoussi F, Galloway MP, Jambekar A, Bame M, 57. 
Needleman R, Brusilow WS. Methionine sulfoximine, an 
inhibitor of glutamine synthetase, lowers brain glutamine 
and glutamate in a mouse model of ALS. J Neurol Sci. 
2010;290:41–7.
Milanese M, Zappettini S, Onofri F, Musazzi L, Tardito D, 58. 
Bonifacino T, et al. Abnormal exocytotic release of glutamate 
in a mouse model of amyotrophic lateral sclerosis. J Neuro-
chem. 2011;116:1028–42.
Rossi S, de Chiara v, Musella A, Cozzolino M, Bernardi G, 59. 
Maccarrone M, et al. Abnormal sensitivity of cannabinoid 
CB1 receptors in the striatum of mice with experimental 
amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 
2010;11:83–90.
Llado J, Haenggeli C, Pardo A, Wong v, Benson L, 60. 
Coccia C, et al. Degeneration of respiratory motor neurons 
in the SOD1-G93A transgenic rat model of ALS. Neurobiol 
Dis. 2006;21:110–8.
Quinlan KA, Schuster JE, Fu R, Siddique T, Heckman CJ. 61. 
Altered postnatal maturation of electrical properties in spinal 
motor neurons in a mouse model of amyotrophic lateral 
sclerosis. J Physiol. 2011;589:2245–60.
Mitchell CS, Lee RH. The dynamics of somatic input 62. 
processing in spinal motor neurons in vivo. J Neurophysiol. 
2011;105:1170–8.
Elbasiouny SM, Amendola J, Durand J, Heckman CJ. 63. 
Evidence from computer simulations for alterations in the 
membrane biophysical properties and dendritic processing 
of synaptic inputs in mutant superoxide dismutase-1 motor 
neurons. J Neurosci. 2010;30:5544–58.
Papadimitriou D, Le verche v, Jacquier A, Ikiz B, 64. 
Przedborski S, Re DB. Inflammation in ALS and SMA: 
sorting out the good from the evil. Neurobiol Dis. 2010;37: 
493–502.
Gowing G, Dequen F, Soucy G, Julien JP. Absence of tumor 65. 
necrosis factor-alpha does not affect motor neuron disease 
caused by superoxide dismutase-1 mutations. J Neurosci. 
2006;26:11397–402.
Meissner F, Molawi K, Zychlinsky A. Mutant superoxide 66. 
dismutase-1-induced IL-1beta accelerates ALS pathogene-
sis. Proc Natl Acad Sci U S A. 2010;107:13046–50.
Yamasaki R, Tanaka M, Fukunaga M, Tateishi T, Kikuchi H, 67. 
Motomura K, et al. Restoration of microglial function by 


































14 R. B. Kim et al. 
Greenberg DA, Jin K. vEGF and ALS: the luckiest growth 68. 
factor? Trends Mol Med. 2004;10:1–3.
Sathasivam S. vEGF and ALS. Neurosci Res. 2008; 69. 
62:71–7.
Danzeisen R, Schwalenstoecker B, Gillardon F, Buerger E, 70. 
Krzykalla v, Klinder K, et al. Targeted antioxidative and 
neuroprotective properties of the dopamine agonist prami-
pexole and its non-dopaminergic enantiomer SND919CL2x 
[()2-amino-4,5,6,7-tetrahydro-6-Lpropylamino-
benzathiazole dihydrochloride]. J Pharmacol Exp Ther. 
2006;316:189–99.
Li B, Xu W, Luo C, Gozal D, Liu R. vEGF-induced activation 71. 
of the PI3-K/Akt pathway reduces mutant SOD1-mediated 
motor neuron cell death. Brain Res Mol Brain Res. 
2003;111:155–64.
Cookson MR, Menzies FM, Manning P, Eggett CJ, 72. 
Figlewicz DA, McNeil CJ, et al. Cu/Zn superoxide dismutase 
(SOD1) mutations associated with familial amyotrophic 
lateral sclerosis (ALS) affect cellular free radical release in 
the presence of oxidative stress. Amyotroph Lateral Scler 
Other Motor Neuron Disord. 2002;3:75–85.
Cassina P, Pehar M, vargas MR, Castellanos R, Barbeito AG, 73. 
Estevez AG, et al. Astrocyte activation by fibroblast growth 
factor-1 and motor neuron apoptosis: implications for 
amyotrophic lateral sclerosis. J Neurochem. 2005;93: 
38–46.
Nguyen T, Nioi P, Pickett CB. The Nrf2-antioxidant response 74. 
element signaling pathway and its activation by oxidative 
stress. J Biol Chem. 2009;284:13291–5.
Kirby J, Halligan E, Baptista MJ, Allen S, Heath PR, 75. 
Holden H, et al. Mutant SOD1 alters the motor neuronal 
transcriptome: implications for familial ALS. Brain. 2005; 
128:1686–706.
Neymotin A, Calingasan NY, Wille E, Naseri N, Petri S, 76. 
Damiano M, et al. Neuroprotective effect of Nrf2/ARE acti-
vators, CDDO ethylamide and CDDO trifluoroethylamide, 
in a mouse model of amyotrophic lateral sclerosis. Free 
Radic Biol Med. 2011;51:88–96.
Foley AM, Ammar ZM, Lee RH, Mitchell CS. Systematic 77. 
review of the relationship between amyloid-beta levels and 
measures of transgenic mouse cognitive deficit in Alzheim-
er’s disease. J Alzheimers Dis. 2015;44:787–95.
Aquilano K, Rotilio G, Ciriolo MR. Proteasome activation 78. 
and nNOS down-regulation in neuroblastoma cells expressing 
a Cu/Zn superoxide dismutase mutant involved in familial 
ALS. J Neurochem. 2003;85:1324–35.
Kieran D, Kalmar B, Dick JR, Riddoch-Contreras J, 79. 
Burnstock G, Greensmith L. Treatment with arimoclomol, 
a coinducer of heat shock proteins, delays disease progression 
in ALS mice. Nat Med. 2004;10:402–5.
Niwa J, Yamada S, Ishigaki S, Sone J, Takahashi M, 80. 
Katsuno M, et al. Disulfide bond mediates aggregation, 
toxicity, and ubiquitylation of familial amyotrophic lateral 
sclerosis-linked mutant SOD1. J Biol Chem. 2007;282: 
28087–95.
Karch CM, Borchelt DR. A limited role for disulfide cross-81. 
linking in the aggregation of mutant SOD1 linked to familial 
amyotrophic lateral sclerosis. J Biol Chem. 2008;283: 
13528–37.
Wooley CM, Sher RB, Kale A, Frankel WN, Cox GA, 82. 
Seburn KL. Gait analysis detects early changes in transgenic 
SOD1-G93A mice. Muscle Nerve. 2005;32:43–50.
Finkelstein A, Kunis G, Seksenyan A, Ronen A, Berkutzki T, 83. 
Azoulay D, et al. Abnormal changes in NKT cells, the IGF-1 
axis, and liver pathology in an animal model of ALS. PLoS 
One. 2011;6:e22374.
Chiu IM, Chen A, Zheng Y, Kosaras B, Tsiftsoglou SA, 84. 
vartanian TK, et al. T-lymphocytes potentiate endogenous 
neuroprotective inflammation in a mouse model of ALS. 
Proc Natl Acad Sci U S A. 2008;105:17913–8.
Mitchell CS, Hollinger SK, Goswami SD, Polak MA, 85. 
Lee RH, Glass JD. Antecedent Disease Is Less Prevalent in 
Amyotrophic Lateral Sclerosis. Neurodegener Dis. 
2015;15:109–13. 10.1159/000369812.
Eisen A. Amyotrophic lateral sclerosis is a multifactorial 86. 
disease. Muscle Nerve. 1995;18:741–52.
de vos KJ, Chapman AL, Tennant ME, Manser C, 87. 
Tudor EL, Lau KF, et al. Familial amyotrophic lateral 
sclerosis-linked SOD1 mutants perturb fast axonal transport 
to reduce axonal mitochondria content. Hum Mol Genet. 
2007;16:2720–8.
Mitchell CS, Lee RH. Pathology dynamics predict spinal 88. 
cord injury therapeutic success. Journal of Neurotrauma. 
2008;25:1483–97.
Oh YK, Shin KS, Yuan J, Kang SJ. Superoxide dismutase-1 89. 
mutants related to amyotrophic lateral sclerosis induce 
endoplasmic stress in neuro2a cells. J Neurochem. 2008; 
104:993–1005.
Supplementary material available online





































SEEKING HOMEOSTASIS: TEMPORAL TRENDS IN 
RESPIRATION, OXIDATION, AND CALCIUM IN SOD1 G93A 
AMYOTROPHIC LATERAL SCLEROSIS MICE 
Cameron W. Irvin, Renaid B. Kim, and Cassie S. Mitchell (2015) 
Published in Frontiers in cellular neuroscience and reprinted. 
ORIGINAL RESEARCH




















of Technology – Emory University,
313 Ferst Drive, Atlanta, GA 30332,
USA
cassie.mitchell@bme.gatech.edu
Received: 17 April 2015
Accepted: 18 June 2015
Published: 01 July 2015
Citation:
Irvin CW, Kim RB and Mitchell CS
(2015) Seeking homeostasis:
temporal trends in respiration,
oxidation, and calcium in SOD1
G93A Amyotrophic Lateral Sclerosis
mice.
Front. Cell. Neurosci. 9:248.
doi: 10.3389/fncel.2015.00248
Seeking homeostasis: temporal
trends in respiration, oxidation, and
calcium in SOD1 G93A Amyotrophic
Lateral Sclerosis mice
Cameron W. Irvin, Renaid B. Kim and Cassie S. Mitchell*
Department of Biomedical Engineering, Georgia Institute of Technology – Emory University, Atlanta, GA, USA
Impairments in mitochondria, oxidative regulation, and calcium homeostasis have
been well documented in numerous Amyotrophic Lateral Sclerosis (ALS) experimental
models, especially in the superoxide dismutase 1 glycine 93 to alanine (SOD1 G93A)
transgenic mouse. However, the timing of these deficiencies has been debatable. In
a systematic review of 45 articles, we examine experimental measurements of cellular
respiration, mitochondrial mechanisms, oxidative markers, and calcium regulation. We
evaluate the quantitative magnitude and statistical temporal trend of these aggregated
assessments in high transgene copy SOD1 G93A mice compared to wild type mice.
Analysis of overall trends reveals cellular respiration, intracellular adenosine triphosphate,
and corresponding mitochondrial elements (Cox, cytochrome c, complex I, enzyme
activity) are depressed for the entire lifespan of the SOD1 G93A mouse. Oxidant markers
(H2O2, 8OH2′dG, MDA) are initially similar to wild type but are double that of wild type
by the time of symptom onset despite early post-natal elevation of protective heat shock
proteins. All aspects of calcium regulation show early disturbances, although a notable
and likely compensatory convergence to near wild type levels appears to occur between
40 and 80 days (pre-onset), followed by a post-onset elevation in intracellular calcium.
The identified temporal trends and compensatory fluctuations provide evidence that
the “cause” of ALS may lay within failed homeostatic regulation, itself, rather than any
one particular perturbing event or cellular mechanism. We discuss the vulnerabilities of
motoneurons to regulatory instability and possible hypotheses regarding failed regulation
and its potential treatment in ALS.
Keywords: ALS, motor neuron disease, mitochondria, oxidative stress, Ca2+, energy metabolism
Introduction
Amyotrophic Lateral Sclerosis (ALS) is a late-onset neurodegenerative disease consisting of
progressive muscle atrophy, muscle paralysis, dysarthria, dysphagia, and dyspnea. While there
has been much research conducted on the disease, the precise causes and effective treatments
have remained elusive. Transgenic mice, and namely the superoxide dismutase 1 glycine 93 to
alanine mutation (SOD1 G93A), have served as the predominant means by which to investigate
the underlying cellular pathophysiology (Pfohl et al., 2015). Amultitude of categorical disturbances
have been identified, which are described in detail in a recent informatics-based systematic review
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of the SOD1 G93A field (Kim et al., 2015): apoptosis, including
changes in pro- and anti-apoptotic signals; energetics, including
mitochondrial dysfunction, adenosine triphosphate (ATP)
depletion, and calcium homeostasis; excitability, including
hypoexcitability, hyperexcitability, and excitotoxicity; genetic
transcription, including damage to mRNA and DNA;
inflammation, due to reactive microglia and astrocytes;
oxidative stress, from the production of free radicals; proteomics,
including the build-up of mutant protein aggregates and reduced
autophagy or proteasome function; and systemic function, which
also includes potential non-neuromuscular contributors.
This Frontiers Research Topic and present study focuses on a
unique and highly inter-related triad of the ALS pathophysiology:
the role of mitochondria, oxidative stress, and altered calcium
homeostasis. Most of the previous experimental work has
focused on identifying the presence of impairments in this
triad using a wide variety of specific methods and measures,
such as recording of the mitochondrial potential, evaluation of
intracellular ATP concentration, electrophysiological assessment
of calcium entry, and measurement of intracellular free radicals.
While the presence of deficiencies in mitochondria, oxidative
regulation, and calcium homeostasis has been well established,
their timing, as a function of ALS disease initiation and
progression, is less understood. The goal of this work is
to evaluate their overall temporal trends, pre-natal through
death, in the SOD1 G93A transgenic ALS mouse model. In
this systematic review of 45 articles, we aggregate in vitro,
embryonic, and in vivo experimental measurements of cellular
respiration, mitochondrial mechanisms, oxidative and anti-
oxidative markers, and intracellular calcium in both SOD1 G93A
transgenic ALS mice and in wild type control mice. We evaluate
the magnitude and statistical trend of these assessments in SOD1
G93A mice compared to wild type mice and examine changes
over the course of the SOD1 G93A mouse life span.
Materials and Methods
The general method includes: (1) identifying and recapturing
published experimental data for SOD1 G93A transgenic mouse
and wild type control mouse assessments of mitochondrial
function, oxidative stress, and calcium homeostasis;
(2) Normalizing recaptured data to temporally compare the
assessed measures; (3) Performing a Gaussian average to
temporally interpolate the values and develop a visual trend line
for each measure and category of measures.
Inclusion and Exclusion Criteria
Potential articles were identified under the PubMed search
criteria of (G93A OR transgenic mouse) AND (ALS OR
“Amyotrophic Lateral Sclerosis”). Initial exclusion criteria
consisted of: non-English language articles; articles for which full-
text pdf downloads were unavailable (see Data Recapture); and
articles labeled as literature reviews.
Keyword searches of recaptured figure captions and within
figure text were performed to find relevant articles from
the initial literature pool (see Data Recapture) using the
following terms: calcium and its permutations, including
Ca2+, Ca, etc.; mitochondria and its permutations (mito∗);
oxidative stress and its permutations (oxid∗), reactive oxygen
species (ROS), free radicals, hydrogen peroxide (H2O2),
nitric oxide (NO), malondialdehyde (MDA), 8-hydroxy-2′-
deoxyguanosine (8OH2′dG), heat shock proteins (HSPs).
Study-specific inclusion criteria required the use of both
non-treated SOD1 G93A and wild type transgenic mice for a
given quantitative experimental measurement. “Non-treated”
consisted of controlled experimental assessments of the measured
parameter(s) without the application of chemicals or processes
meant to intentionally attempt to modify the assessed measures
or related physiology.
Data Recapture
Articles were either downloaded using PubMed Central or
from e-journal subscriptions available from the libraries of
Georgia Institute of Technology and Emory University. Data was
recaptured from the following article locations (Kim et al., 2015),
referred to as entities: article title; abstract; figure captions; within
figure text (x–y axis labels, bar graph categorical labels, legends,
etc.); and data series and response values (e.g., quantifiable
figure/table data). Data was scraped from the full-text pdf article.
Every data point was reviewed by an independent quality control
team to insure complete accuracy.
Categorical Definitions
Given that each study utilizes its own specific measures,
aggregation is a requirement in order to obtain a meaningful
visualization of categorical trends and meta-analysis results.
Experimental measures were aggregated into four main
categories: calcium regulation, cellular respiration, mitochondrial
mechanisms, and oxidative regulation. Sub-categories of
measures are further defined within each category as discussed
below.
Calcium Regulation
The calcium regulation category includes experimental
assessments of intracellular calcium dynamics, including calcium
entry, calcium sinks, free calcium concentration, and calcium
sensitivity. Calcium entry encompassed electrophysiological
measurements of extracellular calcium entering through the
membrane of motoneuron cells (e.g., Ca2+ persistent inward
current, Ca2+ amplitude, Cell Voltage, Cellular Calcium,
etc.). Calcium sensitivity included measures of mitochondrial
membrane sensitivity to a discretely measured calcium challenge.
Calcium sink values encompassed measures of calcium buffering
or calcium capacity. Calcium concentration encompassed
general cytosolic free calcium levels.
Cellular Respiration
The cellular respiration category includes measures of general
respiration rate as well as intracellular concentrations of
ATP and adenosine diphosphate (ADP). Measures of the
general respiration rate include production of heme, oxygen
consumption, or respiration control ratio.
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Respiration Mechanisms
Respiration mechanisms included experimental assessment of
complex I activity, COX activity, Cytochrome C levels, and
general mitochondrial enzyme activity (including Complex III,
IV, V). These parameters are involved the electron transport
chain (ETC), which leads to the production of ATP.
Oxidative Regulation
Experimentally assessed contributors to oxidative stress include
hydrogen peroxide (H2O2) production and the oxidant markers
MDA and 8-hydroxy-2′-deoxyguanosine (8OH2′dG). The
concentration of HSP was also incorporated in the oxidative
regulation category given their neuroprotective effects and
potential impact on the slowing of oxidant-induced symptoms.
Specific HSPs included HSP 25, 27, and 70.
Tissue Sources
In vivo tissues primarily consisted of SOD1 G93A mouse brain
or spinal cord cells; in fact, 35 articles identified at least one of
these two regions as a source. Some articles utilized homogenized
tissue or multiple tissue sources (Leclerc et al., 2001; Damiano
et al., 2006; Johnson et al., 2011; Miana-Mena et al., 2011), which
included spinal cord or brain tissue with other systemic tissues,
such as blood, liver, soleus, diaphragm, and liver. Tissues used for
in vitro assessment were more varied. Cell lines mostly included
standard SOD1 G93A transfected mice cells. However, other
G93A-transfected sources included SH-SY5Y cells (Carri et al.,
1997; Goos et al., 2007; Pesaresi et al., 2011), NSC-34 cells (Liu
et al., 2002; Ferri et al., 2008; Mali and Zisapel, 2009; Crippa
et al., 2010), yeast (Gunther et al., 2004; Kloppel et al., 2010), and
bacteria (Singh et al., 1998).
Analysis
The ratio of SOD1 G93A to wild type (e.g., SOD1 G93A/wild
type) is used to normalize each assessed measure. Each study was
normalized to its own published wild type data. For each included
measure or category of measures, the ratio of SOD1G93A to wild
type is plotted versus time. Data from each article is given equal
weight. For ease of visualization, all in vitro cell line experimental
data is plotted as −20 days and embryonic experimental data is
plotted as −5 days; in vivo data is plotted at its corresponding
post-natal day of experimental assessment. A standard Gaussian
average was performed to interpolate values in-between the raw
experimental data points and to produce trend lines indicative of
the general aggregate behavior of each experimentally measured
parameter.
Results
In total, 262 data points from 45 unique papers were collected
and normalized for inclusion in this meta-analysis. Table 1 shows
TABLE 1 | Categorization, distribution, and sources of included experimental data.
Papers Values Sources
Calcium regulation
Entry 2 12 Johnson et al. (2011), Quinlan et al. (2011)
Sensitivity 2 11 Pieri et al. (2003), Damiano et al. (2006)
Sink 6 14 Pieri et al. (2003), Damiano et al. (2006), Igoudjil et al. (2011), Milanese et al. (2011), Pesaresi et al.
(2011), Tradewell et al. (2011)
Concentration 9 26 Carri et al. (1997), Kruman et al. (1999), Beers et al. (2001), Goos et al. (2007), Guatteo et al. (2007),
Milanese et al. (2011), Nutini et al. (2011), Panov et al. (2011), Tradewell et al. (2011)
Mitochondrial mechanisms
Complex I 1 3 Loizzo et al. (2010)
Enzyme activity 5 49 Leclerc et al. (2001), Jung et al. (2002), Mattiazzi et al. (2002), Wendt et al. (2002), Gunther et al.
(2004)
COX 1 4 Kirkinezos et al. (2005)
Cytochrome C 5 11 Guégan et al. (2001), Jung et al. (2002), Liu et al. (2002), Kirkinezos et al. (2005), Damiano et al.
(2006)
Cellular respiration
Adenosine triphosphate (ATP) 4 21 Browne et al. (2006), Ferri et al. (2008), Mali and Zisapel (2009), Peixoto et al. (2013)
Adenosine diphosphate (ADP) 2 18 Leclerc et al. (2001), Browne et al. (2006)
Respiration rate 7 20 Gunther et al. (2004), Damiano et al. (2006), Cassina et al. (2008), Igoudjil et al. (2011), Panov et al.
(2011), Miquel et al. (2012), Zhao et al. (2012)
Oxidative Regulation
8-hydroxy-2′-deoxyguanosine, 8OH2′dG 1 4 Fang et al. (2010)
Hydrogen peroxide, H2O2 5 7 Singh et al. (1998), Liu et al. (1999, 2009), Takamiya et al. (2003), Kloppel et al. (2010)
Malondialdehyde (MDA), C3H4O2 5 36 Hall et al. (1998), Liu et al. (1999), Fang et al. (2010), Miana-Mena et al. (2011), Seo et al. (2011)
Heat shock proteins (HSP) 5 26 Vleminckx et al. (2002), Batulan et al. (2003), Maatkamp et al. (2004), Jaarsma et al. (2008), Crippa
et al. (2010)
There are four major categories of measures: intracellular calcium, mitochondrial mechanisms, cellular respiration, and oxidative regulation). Sub-categories of measures,
as defined in the Methods, are listed under each category along with the number of included unique articles and extracted data points. Each data point represents a
paired SOD1 G93A and wild type mouse assessment at a discrete time point.
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the experimental data point and article distribution to each of the
defined categories and subcategories of measures. The category,
mitochondrial mechanisms, which contains measurements of
constituents necessary for cellular respiration, includes 67 values
from 10 unique articles. Cellular respiration, which includes
the assessed respiration rate and intracellular concentrations
of ATP and ADP, includes 59 values from 12 unique articles.
The oxidative stress category, which includes oxidative markers
and anti-oxidative HSPs, has a total of 73 values from 14
unique articles. Intracellular calcium, which contains measures
examining intracellular calcium homeostasis, contains 63 data
points from 15 unique articles.
Cellular Respiration is Depressed for Entire
Lifespan
Among the most interesting trends found in this meta-analysis
study is that ATP production, along with general respiration
rates, were found to be depressed for the entire lifespan of
the SOD1 G93A mouse (Figure 1). While it has been well
documented that respiration rates are lowered in ALS (Kawamata
and Manfredi, 2010; Cozzolino and Carri, 2012; Peixoto et al.,
2013) even well before physical pathologies develop (Browne
et al., 2006), this meta-analysis supports the assertion that this
phenomenon is a trend that, at least in the high-copy SOD1G93A
transgenic mouse model, is present since birth. That is, the SOD1
G93A mice have notable depression of cellular energetics well
before symptom onset, and this depression remains throughout
the course of disease progression.
Figure 1 illustrates the ratio of transgenic mouse to wild
type mouse experimentally measured levels of intracellular ATP,
ADP, and respiration rate. All of the in vitro cellular data
(plotted as −20 days in Figure 1) collected for intracellular
ATP concentration and respiration rate fall well below their wild
type counterparts. Examining the mathematical mean of in vitro
measures of ATP and respiration rate reveal that SOD1 G93A
levels are approximately 70% of those seen in wild type, which
is equivalent to a 30% reduction.
Post-natal in vivo assessment of intracellular ATP and
respiration rate in SOD1 G93A mice also shows substantial
depression compared to wild type mice. While ATP and
respiration rate is depressed throughout the life span of the
SOD1 G93A mouse, there appears to be small fluctuations
throughout the disease course. However, more data is necessary
to determine whether these small fluctuations are statistically or
mechanistically meaningful. ATP is at its lowest at the disease
end point, where ATP levels approach only 30% of wild type
(Figure 1). Interestingly, the temporal trend of ADP is slightly
different than ATP and respiration rate. For most of the disease
course, ADP is depressed in a similar manner to ATP and
respiration. However, ADP levels in SOD1 G93A mice show an
interesting rise above wild type control mice that occurs near
the disease end point. This near-death rise in ADP could be
FIGURE 1 | Cellular respiration is depressed for the lifespan of the
SOD1 G93A transgenic mouse model. The ratio of SOD1 G93A to wild
type (SOD1 G93A/wild type) is plotted over time for experimental measures
of adenosine triphosphate (ATP), adenosine diphosphate (ADP), and general
respiration rate. Solid lines illustrate predicted trend lines. For visualization
purposes, in vitro data is plotted at −20 days and in vivo time points are
plotted at their corresponding post-natal day of assessment, 0–150 days.
A gray dotted line is provided to show the expected wild type or
homeostatic value. Trend lines are generated based on a Gaussian average
of the normalized data points.
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attributed to the cells’ inability to convert ADP to ATP, which
would leaveADP in excess. In fact, this same trend in the lowering
of the ATP/ADP ratio is seen in clinical patients (Ghiasi et al.,
2012).
Depression of Mitochondrial Mechanisms
Additionally, measures of mitochondrial mechanisms and signals
necessary for respiration and ATP production are similarly
depressed throughout the course of the disease. Figure 2A
illustrates the temporal trends of four different mitochondrial
mechanism measurements and signals necessary for cellular
respiration: complex I, COX, general enzyme activity, and
cytochrome C. In vitro measures were only obtainable for
enzyme activity, which shows a depression similar to that seen
in ATP levels. Post-natal in vivo assessment of SOD1 G93A
mice reveals that all four of the mitochondrial mechanism
measurements are generally depressed compared to wild type.
The in vivo depression is present at birth and throughout the
entire disease duration. Although the mitochondrial mechanism
experimental measures remain below wild type, the Gaussian
average trend lines identify a potential small bump in
mitochondrial mechanism activity near disease onset (around
80 days), which could represent a regulatory compensation
mechanism; a larger sample size is necessary to determine if this
small bump has possible statistical or mechanistic implications
in disease progression. Finally, when the mitochondria’s ability
to produce ATP is impaired, there is a compensatory increase in
mitochondrial enzyme complexes, especially Complex II, III, IV
(Nalbandian et al., 2015). This upward trend in mitochondrial
enzymes is seen Figure 2A near post-onset and the disease end
point.
Elevation of Oxidants Near Onset
Oxidant levels have been documented as being elevated
throughout different stages of ALS (Liu et al., 2002; Mattiazzi
et al., 2002; Martin et al., 2007), including pre-onset (around
40 days), onset (80 days), and especially end-stage (120+ days).
In Figure 2B we plot the temporal trends of three commonly
measured oxidants in SOD1 G93A mice (8OH2′dG, MDA, and
H2O2). The data presented in Figure 2B reveals that SOD1
G93A intracellular oxidant levels are initially similar to slightly
above wild type at birth. However, by pre-onset, levels are
mildly elevated, and at onset and end point, oxidant levels are
substantially increased compared to wild type. In vitro assessment
of oxidants does not reveal as pronounced of elevation as the
in vivo assessments. In vivo assessment of oxidants reveals a
1.5 factor increase in oxidants compared to wild type around
symptom onset (80 days). In vivo assessment near the SOD1
G93A disease end point (120+ days) reveals oxidant levels that
are a factor of 2–8 times greater than seen in wild type control
mice.
Heat shock proteins, which have an anti-oxidative effect, are
also plotted in Figure 2B. HSPs in SOD1 G93A mice were found
to initially be substantially greater than wild type levels, but
they exhibited a fluctuating decline as the disease progressed.
However, there appears to be a recurrent delayed rise in HSP
as the disease enters the symptomatic stage (around 80 days).
FIGURE 2 | Temporal trends of mitochondrial mechanisms, oxidant
regulation, and calcium regulation in the SOD1 G93A transgenic
mouse model. The ratio of SOD1 G93A to wild type (SOD1 G93A/wild type)
is plotted over time for each experimental measure. For visualization
purposes, in vitro data is plotted at −20 days, embryonic data is plotted at
−5 days, and in vivo time points are plotted at their corresponding post-natal
day of assessment, 0–150 days. A gray dotted line is provided to show the
expected wild type or homeostatic value. Trend lines are generated based on
a Gaussian average of the normalized data points. (A) Mitochondrial
mechanisms (Complex I, COX, enzyme activity, and cytochrome c).
(B) Oxidant markers (8OH2′dG, MDA, H2O2) and protective heat shock
proteins (HSPs). (C) Calcium regulation (entry, sensitivity, sink, and cytosolic
concentration).
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FIGURE 3 | Inter-relationships in the mitochondrial
mechanism-oxidative regulation-calcium regulation triad center
around cellular respiration. Each square is colored based on whether
the assessed category is, on average, higher (green), or lower (red) in
SOD1 G93A mice compared to wild type as determined by the overall
trend line directionality from 0 to 150 days. The color of the arrow
indicates the sign of the relationship, and the size indicates the relative
magnitude.
This fluctuation has been previously described. It is hypothesized
that HSP levels are insufficient to quell the oxidant rise. Thus,
decreased HSP levels actually precede motor neuron loss in ALS
(Maatkamp et al., 2004).
Fluctuations of Intracellular Calcium
Calcium homeostasis is critical for both functional neural
excitability and normal cellular signaling. There are four
main experimental types of calcium regulatory measurements:
calcium entry (incoming calcium through ion channels), calcium
sensitivity (measurement of the cell’s rate of response to calcium),
calcium sink (binding and storage of intracellular calcium,
including buffers, transporters, and intracellular stores), and the
actual calcium concentration (free intracellular concentration).
Each of these measures contributes to the balance or homeostasis
of intracellular calcium.
In vitro data examining free intracellular calcium
concentration is conflicting, with about half of the data points
showing elevated calcium and half showing lower intracellular
calcium compared to wild type (points plotted at −20 days in
Figure 2C). These apparent conflicts in in vitro intracellular
calcium concentration could possibly be explained by the usage
of different tissue types for in vitro assessment (see Tissue
Sources). Measurements of in vitro calcium sinks are depressed
compared to wild type, ranging from 60 to 80% of that seen
in wild type mice, and calcium sensitivity is about 30% of wild
type. Post-natal in vivo assessment of intracellular calcium and
calcium entry at birth reveals levels that are substantially above
wild type. However, free calcium and calcium entry appears to
dip to near-normal levels during pre-onset. There is limited data
for SOD1 G93A mice calcium entry and concentration from
onset through end point, but available data revels that calcium
appears to rise sharply after onset, resulting in a disease end point
intracellular calcium concentration that is a factor 1.5 greater
than wild type. In vivo assessment of calcium sinks and calcium
sensitivity in SOD1 G93A mice show depressed levels compared
to wild type from birth through the disease end point. Intuitively,
the point at which the calcium sink trend line is highest coincides
with the time points when calcium concentration, or free-floating
calcium, is lowest.
Discussion
The results of our systematic review and meta-analysis of 45
articles shed new light on the temporal trends of cellular
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respiration, oxidative markers, mitochondrial mechanisms, and
calcium regulation in the SOD1 G93A transgenic ALS mouse
model. By aggregating data, we show that cellular respiration
and corresponding mitochondrial mechanism are impaired for
the entire lifespan of the SOD1 G93A mouse. Oxidant markers
are initially similar to wild type but are more than double
that of wild type by the time of symptom onset despite early
post-natal elevation of protective HSPs. All aspects of calcium
regulation show early disturbances, although a notable and
likely compensatory convergence to near wild type levels occurs
between 40 and 80 days, which is followed by a divergence after
symptom onset.
This systematic review clearly shows that SOD1 G93A mice
exhibit a long-term metabolic deficit, however, these symptoms
are also present in other ALS mouse models. Dupuis et al. (2004)
performed metabolic experiments on both G93A and G86R mice
to demonstrate the similarities in mitochondrial function. G37R
mice also show significant reduction in ATP production (Coussee
et al., 2011). Finally, substantial metabolic disturbances have also
been documented in non-SOD transgenic mice, including mice




There are multiple feedback loops between the triad of cellular
respiration, calcium regulation, and oxidative regulation. The
inter-relationships between the categories and sub-categories of
measurements examined in this meta-analysis are illustrated in
Figure 3. Red boxes indicate parameters, which are lower in
SOD1G93Amice compared to wild type, and green box indicates
parameters, which are higher in SOD1 G93A mice compared to
wild type. Similarly, the color of the arrows indicates either a
positive relationship (green) or a negative relationship (red), and
their size indicates the relative strength of the relationship. The
biology of these interactions is summarized below.
Mitochondria have a highly interactive dynamic with the
endoplasmic reticulum (ER), the main intracellular calcium
storehouse. Mitochondria take up calcium via the calcium-
sensitive mitochondrial uniporter. However, sustained free
cytosolic calcium inactivates the uniporter, preventing further
calcium uptake (Moreau et al., 2006). Accumulated calcium in
the mitochondria can then be released back into the cytosol
via the sodium–calcium and hydrogen–calcium exchangers
(Fuchs et al., 2013). Once intramitochondrial calcium rises
above a certain level, the mitochondrial transition pore opens,
initiating apoptotic or necrotic signaling cascades (Leung and
Halestrap, 2008). Calcium originating from the activation of
AMPA receptors and/or pathologically increased membrane
permeability is thought to result in this shift of calcium from the
ER to the mitochondria. Ryanodine receptors on the surface of
the ER further amplify calcium-mediated calcium release from
the ER, which in turn, could further exacerbate AMPA activation
(Berridge, 2002). A second receptor that exacerbates calcium
release from the ER is the calcium-activated IP3R.
Collectively, intracellular release of calcium from the ER,
mitochondria, and other intracellular stores could explain the
increase in intracellular cytosolic calcium concentration seen
near onset (∼100 days), which is mirrored by a paradoxical
decrease in extracellular calcium entry (see Figure 2C). Another
contributor for this apparent paradox could be a decrease
in expression of calcium binders like calbindin D28K and
parvalbumin (Celio, 1990), which have been proposed to
result in increased cytosolic calcium in ALS mice (Appel
et al., 2001). Chin et al. (2014) similarly shows a decrease in
parvalbumin in SOD1 G93A mice as well as a reduction in
sarcoplasmic/ER Calcium ATPase proteins, including SERCA1.
Notably, calcium binders, which fall under the calcium sink
category in this meta-analysis, show a slight dip that also
corresponds to the timing of the intracellular calcium increase
(Figure 2C).
Calcium release has a bi-directional relationship with ROS
production since ROS homeostasis is maintained via Ca2+
signaling and Ca2+ dependent pathways. Calcium stimulates
NO synthesis and leads to ROS production at Complex III
(Feissner et al., 2009). Moreover, because the ryanodine receptor
forms a tetramer with the sarcoplasmic and ERs, the reversible
oxidation of endogenous superoxide groups can result in the
release of additional calcium from the sarcoplasmic reticulum
(Fill and Copello, 2002). Finally, oxidative agents like peroxide
directly induce calcium release from the ER via IP3R (Wesson
and Elliott, 1995). In summary, free radicals induce calcium
leakage into the cytosol via the ryanodine receptor, Ca2+-
leak channels, and inositol 1,4,5-trisphosphate receptors, and
conversely, intracellular calcium concentration activates NOX
and NOS, which then produces additional excess ROS and
RNS, respectively (Chin et al., 2014). Ultimately, elevated
internal calcium creates a cyclical feed forward mechanism that
continually increases calcium and oxidative stress to the point of
apoptosis (Chin et al., 2014).
Lower respiration rates, and consequently, lower intracellular
ATP concentrations, directly contribute to the lowering of the
mitochondrial potential, which can ultimately initiate apoptotic
cascades. The impact of lower ATP concentration on oxidative
and calcium imbalances is bi-directional, with increases in
oxidants and calcium-mediated calcium release further impairing
mitochondrial function, especially Complex 1, a key constituent
for ATP production (Cassina et al., 2008; Cozzolino and Carri,
2012; Lautenschlager et al., 2013). Through a less direct path,
an increase in oxidative stress can also lead to a swelling
of mitochondria, which also further inhibits ATP production
(Martin et al., 2007). Finally, lower concentrations of ATP impede
calcium-ATPase in removing free calcium from the cytosol or
shuttling calcium back to the ER for storage (Kaplan et al., 2003;
Fuchs et al., 2013).
Deciphering the Timing: Cause, Effect, and
Instability
Because of their large size and innate emergent properties,
motoneurons are susceptible to homeostatic instabilities. It
has been previously shown that motoneurons, even in a
physiological state, have insufficient mitochondrial capacity to
buffer large calcium fluxes. Calcium buffering insufficiency is
thought to be due to a reduced mitochondrial density per
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volume compared to non-motoneurons (Grosskreutz et al.,
2007). Therefore, mitochondrial dysfunction and impaired
calcium homeostasis is hypothesized to account for the selective
vulnerability of motoneurons (Jaiswal and Keller, 2009; Jaiswal
et al., 2009). Another contributor for the selective vulnerability
of motoneruons is the requirement for axonal transport of
mitochondria over very long distances, up to 1 m (Mitchell and
Lee, 2009, 2012a; Lee and Mitchell, 2015). Finally, the dynamics
of somatic input processing of motoneurons could explain the
earlier death of fast twitch fibers in ALS (Mitchell and Lee,
2011).
Because there are so many interacting variables, it is difficult
to determine which parameter(s) initiate versus simply affect
the pathophysiological cyclical cascades of depressed cellular
respiration, imbalances in calcium homeostasis, and intracellular
elevation of oxidants in ALS. The presented data reveals that
elevated oxidants appear later in the SOD1 G93A life span,
closer to disease onset. However, both calcium and cellular
respiration/mitochondrial mechanisms show early deficits. Much
like the age-old question, “What came first, the chicken or the
egg?” This meta-analysis begs the question, “What comes first—
improper calcium homeostasis or depressed cellular respiration?”
Scientifically justified arguments could be made for either
position. Increased calcium permeability or ATP depletion from
sub-par cellular respiration, or a combination of both, could
initiate a dynamic instability in themotoneuron that results in the
ALS phenotype. The trend lines presented in this meta-analysis
reveal the presence of potential compensatory mechanisms,
which attempt but ultimately fail, to re-stabilize to homeostasis.
For example, between 0 and 20 days, there is a rise in HSPs and
a gradual increase in calcium sensitivity. The “slight bump” in
mitochondrial mechanisms/cellular respiration at pre-onset also
coincides with the lowest intracellular calcium levels. Attempts
to re-stabilize to homeostasis could potentially correspond to
the small fluctuations apparent in Figures 1 and 2, although
more data is needed to definitively determine their statistical
significance.
Mathematical instabilities within pathophysiological feedback
loops have already been identified in a dynamic meta-analysis
of the SOD1 G93A mouse model (Mitchell and Lee, 2012b). If
unstable pathology dynamics are the actual underlying culprit,
it may not actually matter exactly which mechanism first
initiated the cascade (see Future Directions). Both preclinical
and clinical failures to obtain meaningful success using single-
mechanism treatments illustrate the potential validity of this
point. Among the many examples are: dichloroacetate (Miquel
et al., 2012), which attempts at restoring the mitochondrial
respiratory capacity in the astrocytes, N-acetyl-glucagon-like
peptide-1 (Sun et al., 2013), which endogenously regulates
metabolism by promoting insulin synthesis and secretion, and
creatine (Groeneveld et al., 2003; Snow et al., 2003; Beal, 2011),
which is known to enhance ATP synthesis. However, no single
treatment to targeting cellular energetics has been effective
enough to translate to an effective treatment for humans (Tadic
et al., 2014).
In this meta-analysis, we reveal that, although there are some
small fluctuations, cellular respiration is depressed for the entire
SOD1 G93A ALS mouse lifespan. Interestingly, ALS patients,
prior to the onset of their ALS, have been found to be healthier
(e.g., less antecedent disease) than age, gender, and geography-
matched control subjects (Mitchell et al., 2015). However, such
patients could still have asymptomatic pre-ALS variations in
their underlying motoneuron regulation, which make them
more susceptible to instabilities. Hypervigilant regulation as
been put forth as one possibility to explain how the above-
average pre-ALS health of patients could be correlated to a
later, destabilizing motoneuron perturbation, which initiates ALS
(Mitchell et al., 2015). “Hypervigilant regulation” results when
underlying regulatory processes aggressively overreact to correct
imbalances from homeostasis, making them ‘hypervigilant’ to
perturbation (in control theory, referred to as a too-high feedback
gain). While hypervigilant regulation would initially be overall
protective, it could also result in greater later susceptibility
to destabilization, especially in highly susceptible motoneurons
(Mitchell et al., 2015). The temporal calcium, oxidant, and HSP
fluctuations identified in this study, in combination with the
oscillatory behavior of other previously identified parameters
(Mitchell and Lee, 2012b) such as axonal transport (Mitchell and
Lee, 2012a) and excitability (Delestree et al., 2014), are suggestive
of the possible role of regulatory and homeostatic impairments as
being the “cause” of ALS.
Future Directions
Perhaps instead of focusing on mechanistic initiation, treatments
should focus on treating the underlying instability, itself (Mitchell
and Lee, 2008, 2012b). Whether in engineering process or in
biology, treating instability typically requires impacting multiple
targets or feedback loops, which may or may not have directly
initiated the destabilizing perturbation or event. Combination
treatments can leverage synergistic interactions to increase
treatment effect size. Multiple experimentalists have attempted
combinatory treatments on the SOD1 G93A mouse model
(Waibel et al., 2004; Feng et al., 2008; Del Signore et al.,
2009; Del Barco et al., 2011). For example, Waibel et al.
(2004) experimented with rasagiline, an anti-apoptotic with
neuroprotective properties, combined with riluzole, a sodium
channel blocker, to reduce excitotoxicity. The combinatory
treatment did exhibit a statistically significant improvement
compared to control and compared to Riluzole alone.
In addition to exploiting synergistic interactions to increase
effect size, combination treatments could potentially be used
to re-stabilize the system to homeostasis. Theoretical SOD1
G93A ALS models of combination treatments have shown
this exciting possibility (Mitchell and Lee, 2012b). In fact,
of the several thousand computationally assessed combination
treatment permutations, a few percent of 2 and 3-way
treatment strategies were able to mathematically stabilize the
ALS pathophysiology (Mitchell and Lee, 2012b). Interestingly,
energetics was one of the pathophysiological categories that
most frequently appeared in synergistic or stabilizing treatment
combinations. Given the early and lasting depression of ATP
and respiration rates identified in the present study, it is not
surprising that energetics was previously predicted to have the
greatest single-category effect size (Mitchell and Lee, 2012b).
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Based on the results of the present study, it would appear
that therapeutics leveraging the strong interactions within
the calcium-respiration-oxidation triad could be promising.
As shown in Figures 1 and 2, prior to onset, it appears
the SOD1 G93A physiology temporarily compensates toward
decreasing intracellular calcium, increasing anti-oxidative HSPs,
and slightly increasing respiration rate; thus, treatment to amplify
these existing compensatory mechanisms would seem intuitive.
However, like spinal cord injury (Mitchell and Lee, 2008),
such treatments would likely have to be initiated very early
in the disease process to have a meaningful effect. In fact, in
the case of instability, the timing of treatment may be the
most important parameter, especially given human patients will
not be treated until after ALS symptoms appear. Obtaining
a finer point on the timing and statistical significance of
fluctuations in intracellular calcium, ATP concentration, and
free radicals, is critical to devising combination treatments
that have clinically significant results. An additional essential
research path is better assessment of homeostatic regulation.
Modulation of regulatory pathways may prove more fruitful for
re-stabilization than direct physical or chemical manipulation of
cellular elements.
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Biocuration is a time-intensive process that involves 
extraction, transcription, and organization of biological or 
clinical data from disjointed data sets into a user-friendly 
database.  Curated data is subsequently used primarily for 
text mining or informatics analysis (bioinformatics, 
neuroinformatics, health informatics, etc.) and secondarily 
as a researcher resource.  Biocuration is traditionally 
considered a Ph.D. level task, but a massive shortage of 
curators to consolidate the ever-mounting biomedical “big 
data” opens the possibility of utilizing biocuration as a 
means to mine today’s data while teaching students skill 
sets they can utilize in any career.  By developing a 
biocuration assembly line of simplified and 
compartmentalized tasks, we have enabled biocuration to 
be effectively performed by a hierarchy of undergraduate 
students.  We summarize the necessary physical 
resources, process for establishing a data path, biocuration 
workflow, and undergraduate hierarchy of curation, 
technical, information technology (IT), quality control and 
managerial positions.  We detail the undergraduate 
application and training processes and give detailed job 
descriptions for each position on the assembly line.  We 
present case studies of neuropathology curation performed 
entirely by undergraduates, namely the construction of 
experimental databases of Amyotrophic Lateral Sclerosis 
(ALS) transgenic mouse models and clinical data from ALS 
patient records.  Our results reveal undergraduate 
biocuration is scalable for a group of 8-50+ with relatively 
minimal required resources.  Moreover, with average 
accuracy rates greater than 98.8%, undergraduate 
biocurators are equivalently accurate to their professional 
counterparts.  Initial training to be completely proficient at 
the entry-level takes about five weeks with a minimal 
student time commitment of four hours/week. 
     Key words: biocuration, text mining, database, 
biomedical informatics, bioinformatics, neuroinformatics, 
health informatics, data science, lab management, big 




Defined by the International Society for Biocuration, 
biocuration involves the translation and integration of 
information relevant to biology or medicine into a database 
or resource that enables integration of the scientific 
literature as well as large data sets.  The primary goal of 
biocuration is to accurately and comprehensively present 
integrated data as a user-friendly resource for working 
scientists and as a basis for computational analysis.  There 
has been rapid expansion of published literature, 
experimental data, electronic clinical records, and 
continuous health monitoring data.  The curation of 
biomedical data has become a necessity to explore new 
problem domains using informatics analysis, a field more 
recently referred to as “big data.”  In fact, because of the 
magnitude and breadth of available data and the 
development of innovative informatics analysis techniques, 
biocuration is quickly becoming one of the most invaluable 
research aids. 
     Curation of any kind of biomedical data or literature is 
typically considered a Ph.D. level task due to the integrated 
level of knowledge required to classify complex information 
(Burge et al., 2012).  While automated tools exist to 
expedite the process, biocuration currently remains a 
largely manual and time-consuming task.  The level of 
education and the required manual labor and time are 
critical reasons why there is a massive shortage of 
biocurators (Burge et al., 2012).  On the other hand, the 
number of undergraduates wishing to obtain research 
experience and crucial career-enhancing data analytical 
skills is nearly unlimited.  To this end, we have developed a 
biocuration process that enables undergraduates to 
successfully curate biomedical data at accuracy and 
productivity rates that equal professional curators. 
     Our approach includes partitioning the complex 
biocuration process into digestible steps that collectively 
encompass a serial assembly line, which can be operated 
by a “small army” of undergraduate biocurators, from 8-50+ 
per semester.  By dispersing the workload, each 
undergraduate curator works a reasonable but effective 
four hours/week, thereby preventing burnout.  Another 
important part of undergraduate biocuration success is the 
creation of an undergraduate lab environment that closely 
resembles a business structure with a hierarchy of curator, 
technical, managerial, and administrative positions.  
Curation is the foundational layer of the hierarchy.  
However, the business structure creates additional 
opportunities for undergraduate skill set development for 
both academic research and traditional industry careers 
while simultaneously alleviating the managerial time 
commitment of the primary investigator (PI)/professor. 
     In this article, we outline the process utilized to initiate 
and maintain an undergraduate biocuration assembly line.  
This method is ideally suited to informatics/theoretical labs 
or primary investigators/programs who wish to establish 
undergraduate research positions suitable for students 
headed either into academic research or industry.  Smaller-
scale versions could also be envisioned in 
wet/experimental/clinical labs that have their own large 
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data sources that they wish to curate.  Compared to many 
research projects, biocuration requires very little start-up 
financial or physical resources while still offering amazing 
career-transforming opportunity for undergraduates.  
Moreover, the developed curated database products and 
enabled informatics analysis is invaluable to biomedical 
data science. 
     Because our lab’s primary area of expertise is 
computational analysis of neurophysiology and 
neuropathology, all of our biocuration has focused on 
neuropathology of disease (Amyotrophic Lateral Sclerosis, 
Alzheimer’s Disease, Spinal Cord Injury).  However, this 
method is adaptable to any experimental (in vitro, in vivo, 
physiology or pathology) or clinical data set. 
 
METHODS 
Biocuration involves first establishing a data path as well 
as developing a human workflow.  Below we summarize 
the required resources and the data path process and go 
into detail on how an assembly line of curators and 
hierarchical undergraduate research positions can be 
utilized as a “undergraduate curation corporation.” 
 
Required resources 
Other than a data source and eager undergraduate 
students, the physical resources needed include basic 
computers with standard office productivity software, 
database software, a database server, and a secure local 
area network from which the database server runs such 
that users can simultaneously enter data into a remote 
database.  A quiet purpose-specific environment is 
preferable.  Security of the database and the environment 
must be assessed depending on the type of data being 
curated (e.g., clinical data curation requires many more 
security protections compared to experimental data).  For 
our ALS informatics project, curation was done on project-
specific computers in a room with a closed door with 
multiple layers of environmental (controlled access) and 
computational security (multiple logins, firewalls, etc.).  
Resources required for automated and/or manual database 
back up must also be in place. 
 
Establishing a data path 
Establishing the data path includes instituting the process 
from accessing the data to database development to 
curating the data to the ability to analyze the data.  Note 
that, while initially serial, a data path is an iterative loop.  
That is, there are always more refinements as the curation 
project progresses.  Bicourators of different sub-fields each 
have their own personal preferences for establishing a data 
path.  Here we summarize the activities for establishing a 
data path that we believe work best for undergraduates. 
     Data source.  The first step to developing 
undergraduate biocuration is to establish one or more large 
data sources to begin curating.  Data sources could be 
clinical medical records, unpublished experimental data, or 
published experimental data.  When establishing a data 
source, simply keep in mind that the point of biocuration is 
to pool and organize data sets into a form that is both 
useable to other researchers and can be used to perform 
bioinformatics analysis.  Also, determine that all protocols 
for permission and approval to data access (e.g., Internal 
Review Board for clinical data, etc.) are in place. 
     Data pool.  The next step is to establish what parts of 
the data source will be curated.  Being as inclusive as 
possible is usually the best option.  More metrics allow 
more analytical options and more complex research 
questions to be pursued.  Quantitative metrics are the most 
preferred, but parametric data is also valuable.  Any data 
that has pervasive commonality (e.g., a survey that all 
patients have in common) or can be standardized or 
normalized (e.g., a biomedical experiment that includes a 
wild type or control) should definitely be included. 
     Alpha curation.  Before the development of a database, 
a group of alpha testers employ individualized manual 
methods to collect entries from the data pool.  Collecting 
data in a database program or even a simple spreadsheet 
is acceptable.  Having multiple testers helps to include 
multiple points of view.  These test curators, with the PI, 
establish the data fields and the initial anticipated workflow. 
     Establish database.  Based on the alpha curation, a 
relational database is created that allows entry, review, and 
easy export of curated data for statistical analysis.  We use 
the Filemaker (Filemaker, Inc.) database software, 
because, in our experience, it is more friendly and intuitive 
for novice database users, both in terms of layouts 
(graphical user interfaces) and in scripting language.  
However, Access (Microsoft, Inc.) or any other preferred 
database platform could be utilized. 
     Beta curation.  Before the database is released for 
official curation by a large group, beta testers not involved 
in the construction of the database use the database to 
identify bugs, suggest edits in design, or suggest addition 
of  automation/user tools to reduce error.  The database is 
refined based on beta curator input. 
     Workflow.  The order in which the data is curated and 
how it is formatted must be explicitly specified.  The 
development of written protocols is key to insure data 
homogeneity and integrity. 
     Primary curation.  Primary curation is the bulk of 
curation performed as part of the main project or database 
construction. 
     Data quality control.  Establishing manual and 
automated data quality control procedures is critical for 
insuring data integrity.  These procedures will vary slightly 
depending on the curated data type.  More detail is given in 
the Quality Control section under Positions. 
     Classification.  After a substantive amount of primary 
curation, classifications (such as functional ontologies) can 
be imposed to assist in searching, aggregating, and 
analyzing data.  We recommend designing for both a 
universal ontology, to be used by any database user, and 
user-specified ontologies, to be used and customized by 
specific tech teams (see Positions) as part of their analysis. 
     Prioritization.  For very large biocuration projects, 
developing a prioritization scheme can be helpful to 
insuring that the most important or time-sensitive data or 
data relevant to the pilot projects’ goals is curated first. 
     Meta-data analysis.  Meta-data simply means “data on 
the data.”  Meta-data of curated data in the database is 
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used to determine sample sizes, which specify the 
feasibility of a pilot project’s goals. 
     Feasibility study.  A feasibility study is the process of 
evaluating potential pilot project alternatives based on 
meta-data, scientific or clinical significance or user need. 
     Pilot project.  A pilot project is a research project that 
utilizes the curated database for exploratory or hypothesis 
driven research or to develop a product.  Depending on 
available sample sizes and timelines, it may or may not be 
a full-size study.  Some pilot projects can develop into full-
size studies once proof-of-concept has been obtained. 
 
Applicants 
Applicants range from high school juniors through senior 
undergraduate students.  As shown in Figure 1, our 
applicants come from a variety of majors, including all 
different types of engineering, biological science, chemisty, 
computer science, business/finance majors, and many 
others.  Irrespective of major, most applicants seek us out 
due to their perceived interest in neuroscience or medicine.  
Because we are in the biomedical engineering (BME) 
department, the majority of applicants are BME majors.  
Many of the BME majors and especially the non-BME 
majors have a pre-health track, which means they have 
had requisite exposure to basic biology knowledge and 
quantitative skills necessary for curation.  Applicants 
complete our lab’s official application and submit a one-
page resume.  The application is a combination of 
questions, including questions to assess personality, 
attention to detail, interests/extracurricular activities, 
classwork, special skill sets, future career plans, and 
perhaps most importantly, a paragraph written by the 
applicant stating why they desire a position.  An in-person 
interview by the PI is utilized to assess intangible qualities. 
     Unlike many labs seeking undergraduates, we don’t 
simply target “the crème de la crème” with the highest 
GPA, etc.  In fact, we have found that GPA is not even a 
good predictor of success in a biocuration and informatics 
environment.  Desire, commitment, consistency, attention 
to detail, and fundamental biological and quantitative 
knowledge (e.g., how to read a graph or an experimental 
protocol, etc.) appear to be the essential basic applicant 
qualities at the entry-level.  Every person starts at the 




As shown in Figure 1, there are three phases of initial 
training: introductory lectures, project training and curation 
training.  Introductory lectures are classroom-style teaching 
sessions where associates are given a primer on 
biocuration, an overview of basic neuroscience, and 
fundamental scientific and/or clinical knowledge on the 
topic/condition/pathology being assessed.  Interactive or 
hands-on project training teaches the applicants everything 
they specifically need to know about the project, especially 
the types of measures being curated and their definitions, 
and any ethical or research protocols for handling the data.  
For example, most of our clinical ALS informatics project 
associates had at least a one-day rotation at an ALS Clinic  
 
 
Figure 1.  Application, training, and job positions.  ALS clinical 
informatics project used as a detailed example. 
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to help them better understand the information that was 
being curated in the chart.  Interactive or hands-on curation 
training teaches the applicant everything they need to 
know in terms of data transcription—how to access the 
data, how to use the database software, how the database 
is organized, and ultimately how to find/search, view, edit 
and add new data  
     Exams testing concept recall immediately follow each 
training session.  The curation training session also has a 
practical exam where students curate specified data into 
their own individual practice database for a period of one 
week.  A score of 95% is required to pass the practical 
exam.  Individualized tutoring and up to two retakes are 
allowed before dismissal.  Upon passing the practical, 
students undergo a competency assessment, which is a 
four-week period of live curation in the actual project 
database.  If the associate shows good promise in meeting 
the quality control productivity and accuracy standards and 
has consistently worked their specified schedule, they are 
finally offered a contracted position. 
 
Positions 
     Curators:  Curation is our foundational and entry 
task/position.  Curators collect/transcribe data and enter it 
into the project-specific database.  Whether an associate is 
a senior in high school or a senior in college, he/she will 
begin as a curator.  The amount of expertise required for 
curation will vary by project.  For very complex data paths 
and/or to lower the experience barrier for applicants, 
curation can be divided into different “levels” that form a 
serial assembly line.  Curators are promoted to each 
subsequent level as they gain the necessary experience 
and training and prove their desire and skill.  For example, 
our SOD1 G93A ALS transgenic mouse informatics 
projects has multiple levels of curators:  1) document 
capture—Level 1 associates access and save the data files 
(in this case, published articles) in an organized, 
appropriate format for subsequent transcription; 2) figure 
capture—associates transcribe figure captions by panel.  
3) data series capture—associates transcribe non-
interpretative experimental parameters names, 
experimental methods, mouse genotypes, etc.; 4) 
response value capture—associates transcribe quantitative 
data, which may or may not require subjective 
interpretation by reading data from a figure, etc.; 5) 
informatics capture—capturing additional project-specific 
data, applying organization or ontological schemes, or 
even doing meta-data analysis.  In essence, these curators 
serve as consultants to the technical teams. 
     Despite detailed initial training, there are always 
questions that occasionally surface in regards to specific 
entries.  We developed a “curator que” that uses a freely 
available online interactive classroom website (Piazza), 
which we have adapted for posting questions/answers, 
reminders, and tips.  Quality control managers respond to 
posted questions within 24 hours. 
     Most curators work a reasonable but effective 4-6 
hours/week.  This amount of workload is perfect for 
associates who are assessing their interest.  Moreover, in 
an assessment of curator workload, we have determined  
that 4-6 hours/week results in optimal productivity and 
accuracy.  Curation is a very detail-oriented task, and this 
must be considered when determining the workload (hours 
worked and required productivity).  In fact, we prefer that 
associates work in multiple two-hour intervals versus a 
continuous four or six hours.  Online scheduling is utilized 
to manage computer access, which optimizes computer 
resource requirements and insures curators always have a 
computer when they come in to the lab to work their 
scheduled time periods.  Our typical curator tenure is about 
three semesters, with a percentage of students being 
promoted to tech teams at the end of semester two.  
However, many students work as a curator much longer 
than the average simply because they enjoy the task or the 
time required fits their schedule while still satisfying their 
desire to participate in research. 
     Quality Control (QC): Just like any manufacturing 
process or company, the purpose of quality control is to 
ensure that the product (i.e., the database) and performed 
service (i.e., biocuration) adheres to a defined set of quality 
criteria.  Our QC personnel quantify curator productivity 
and accuracy, and provide weekly feedback and required 
corrections.  Quality control personnel are typically highly 
skilled former curators who wish to obtain real-world 
management experience.  As such, many have aspirations 
to do industry research and development project 
management.  Most QC personnel work eight hours/week, 
although the minimum is four hours/week. 
     A written quality control protocol specifies how 
automated script checks and visual inspection of entries 
should proceed for each data source and curation type.  
This insures consistency among QC personnel.  The lead 
QC manager also monitors the efficacy and consistency of 
QC personnel via random visual inspection and automated 
statistical analysis.  The training of the quality control team 
is similar to the biocuration training: it consists of a hands-
on workshop, a concept exam testing QC protocol 
knowledge, and a competency exam assessing their 
performance of entries.  The QC personnel to biocurator 
ratio ranges from 1:5 to 1:10, depending on the degree of 
complexity of the curation and the amount of available 
automation as part of the QC process. 
     The quality control process, itself, consists of the QC 
personnel using a combination of automation and visual 
inspection to check curated entry accuracy and curator 
productivity.  For every single entry in the curated 
database, there is an associated scribe ID, creation time 
stamp, and modified time stamp so that we can track when 
the entry was made, modified, and who completed it.  Each 
week, quality control personnel are randomly assigned a 
list of associates’ work to check.  Automation works well for 
finding most missing entries or fields, typos/mis-spellings, 
assessing qualitative entries, and checking for formatting.  
Automation also works well for calculating productivity 
(entries completed over a specific time period).  However, 
to determine if quantitative data is entered correctly or if all 
possible data has been gathered from the data source, QC 
personnel must visually inspect and compare the curator’s 
entry to the data source.  The QC personnel complete a 
feedback form for each curator detailing their mistakes and 
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positively commenting about good performances (e.g., 
accurately entering a very complex figure, etc.) as 
appropriate.  The feedback cites the database field keys for 
each entry that requires modification.  The curators have 
one week to fix identified mistakes before re-checking by 
QC personnel. 
     For each curation level, there is an associated 
requirement for productivity and accuracy.  Prior to 
corrections, we set the required curator weekly accuracy 
standard to be 97.5%.  This rate was based on accuracy 
standards referenced by other academic and industrial 
curation projects using Ph.D. biocurators (see Results).  
Nonetheless, our actual accuracy rate prior to correction is 
98.8%.  Productivity requirements vary by curation level 
and project.  We utilize beta tests during data process 
development to determine productivity standards.  The 
general rule of thumb is that the productivity standard is 2 
standard deviations below the beta test average.  This 
method ensures that the productivity standard provides 
ample motivation to be efficient but is also sufficiently low 
so as to not rush or penalize a curator for doing a thorough 
job or taking a little time to learn about data along the way. 
     A point-based system is used to track productivity and 
accuracy for both penalization and reward.  Penalty points 
for not meeting quality control standards are used for 
performance grading and determining readiness of 
promotion (see Performance Review). 
     Technical Teams:  About 60% of our curators go on to 
join a technical or “tech” team.  Tech teams consist of 2-5 
students who perform small pilot data science projects 
using curated data.  Projects may be exploratory or 
hypothesis-driven.  All teams start by assessing meta-data 
and creating any necessary classification or ontologies.   
Teams are typically paired with one or two curator 
consultants to expedite getting the data in the form the 
team needs for their specific project.  In our lab, 
exploratory studies utilize complex systems-based 
techniques to identify relationships within the data and 
testable hypotheses.  Traditional hypothesis-driven studies 
typically consist of large-scale meta-analyses or the use of 
standard statistics to answer a specific question.  Tech 
teams, on average, require three semesters to complete a 
published article although we have had several extremely 
motivated teams submit an article or conference 
proceeding after two semesters.  A few teams also develop 
data science tools to improve and automate our curation 
process. 
     Tech team project penultimate deliverables or outcomes 
can vary based on both the PI’s desires (ongoing projects 
and deadlines) and the team members’ desires (long-term 
career goals like authoring an article in preparation for 
graduate school, development of specific skills for industry, 
planned tenure in the lab, school schedule, etc.).  Typically, 
we have had the best success if the penultimate 
deliverable was a useable product/tool by the lab or public, 
a published conference proceeding, or a peer-reviewed 
journal article.  Such deliverables encourage and externally 
motivate not only the tech teams, but also the curators.  
Some continuity within teams (i.e., one or more team 
members seeing the tech team project to completion) is 
preferred but is not necessarily a requirement with proper 
documentation and, if possible, a hand-off or transition 
period that includes start-up training and/or an 
apprenticeship by at least one of the new team’s members. 
     The primary investigator provides one or more broad 
topics, questions, or product goals from which the team 
can pursue to choose.  However, it is up to the tech team 
to shape the chosen path into successful project.  A senior-
level experienced undergraduate technical team manager 
handles day-to-day management of tech teams, which 
have pre-set weekly intermediate deliverables set by the 
PI.  Initially, tech teams are given tasks that include 
project-specific curation combined with intense literature 
searches or the equivalent thereof to become proficient on 
the background of their project’s topic.  Common technical 
skills (how to use reference software, export data, make a 
figure, scientific writing, etc.) are taught in sessions led by 
tech team managers.  After ascertaining a knowledge 
background, the focus then shifts to activities beyond the 
primary curation data process (see Establishing the data 
process).  The first semester concludes with a feasibility 
study assessing pilot project alternatives, one of which the 
tech team ultimately pursues in the next semester. 
     After semester one, a tech team is analogous to a 
graduate student fulfilling his/her research proposal.  Tech 
team managers are still available to teach specific common 
statistical/analytical skills (meta-analysis, ANOVA, cox 
proportional hazards, Kaplan-Meir, etc.) and to oversee 
day-to-day productivity and intermediate deliverables.  
However, the PI/professor oversees the tech team project 
direction as the research becomes more project-specific, 
especially during the construction and formatting of the 
penultimate deliverable. 
     Information Technology (IT) Team.  The IT team is 
really just another specialized form of a tech team whose 
focus is on enhancing IT aspects of biocuration rather than 
performing analytical informatics on a particular research 
question.  Thus, some of our associates with high-end 
computer skills or IT-related career plans choose to join 
our IT team instead of a traditional research tech team.  
The IT team refines the database and develops automation 
to enhance curation workflow, quality control, and pilot 
project informatics analysis.  They may also serve as 
consultants to tech teams by assisting in writing scripts or 
other programming tasks.  Finally, the IT team is 
responsible for all IT maintenance, including weekly back-
ups, login accounts, servers, hardware and software. 
     Management.  As noted in the above sections, there are 
undergraduate managers for curation quality control, IT, 
and tech teams.  Technical team managers, who are 
senior-level students, oversee the daily activities of the 
technical teams; lead skills training sessions (using 
reference software, making figures, scientific writing tips) 
and provide consulting for statistical and informatics 
analysis.  QC managers direct the curator que (online 
system for asking curation questions), maintain our training 
and QC protocols, and oversee the curator and quality 
control personnel master schedules.  Our IT managers 
coordinate and oversee all of the IT team’s activities. 
     Our managers are mostly advanced students that have 
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been with us for the majority of their undergraduate tenure.  
Minimally, they must have completed all levels of curation.  
In fact, QC or IT managers are only required to have 
previously completed curation.  However, undergraduate 
tech team managers must have completed curation and at 
least one and preferably two semesters as a tech team 
member.  Managers may also be technicians or graduate 
students.  The commonality among all of the managers is 
that they oversee the day-to-day activity of their core group 
and the submission of weekly and monthly productivity 
reports.  They are also the primary point-of-contact to the 
PI/professor.  Managers are mostly trained through an 
apprenticeship system, although our lab does have specific 
written protocols in place regarding the responsibilities of 
each managerial role. 
 
Performance Review 
As noted in the quality control section, a point-based 
infraction system is used to grade curator accuracy and 
productivity.  A similar system is used to grade technical 
team and manager productivity via the use of weekly or bi-
weekly intermediate deliverables.  All students are given 
contracts at the beginning of each semester that outline the 
expectations for their position(s) and the equivalent points 
which translate to a specific performance grade.  Students 
are given weekly feedback on their performance, so there 
are no surprises.  Students must maintain a “B” to have 
their contract renewed the following semester.  
Consistently poor performance during a semester results in 
demotion to a lesser position (for example, a Level 2 
curator may be demoted to Level 1).  If productivity 
standards for the demoted position are not met, the 
student’s contract is ultimately rescinded.  A total of three 
communicated warnings precede dismissal.  Dismissal is 
done in an in-person meeting with the PI. 
     On a more positive note, Biocurator-of-the-Month 
awards, which include a small prize and a publicly 
displayed certificate on the lab door, are given to the most 
productive (e.g., entries/hour) biocurator(s) who also did 
not incur penalty points for excessive errors.  Analogously, 
technical-associate-of-the-month awards recognize 




During the initial training and competency assessment 
period (approximately six weeks), students are 
uncompensated.  For their first three semesters with a 
position, most students take optional research course 
credit at the rate of 3-4 working hours per credit hour, 
depending on position type.  For subsequent semesters, 
managers and exceptional technical team members may 
receive hourly pay if PI funds are available.  Many of the 
exceptional student researchers apply for and receive 
independent research funding through the university’s 
undergraduate research program (Georgia Tech 
President’s Undergraduate Research Award) or other 
outside similar programs.  In general, curators are not 
given authorship on articles, although in special cases, 
Level 5 curators who serve as consultants may be 
considered.  Authorship is generally reserved for tech team 
members, and is discussed as part of the initial tech team 
establishment. 
 
Primary Investigator Commitment 
As one might expect, leading an “undergraduate 
biocuration corporation” can be a substantive time 
commitment to the primary investigator.  Nonetheless, the 
commitment is manageable with PI scheduling forethought.  
The greatest amount of time is spent with the initial set-up 
(writing of the curation and management protocols, 
determining data sources and possible technical project 
topics, and interviewing/training the first batch of students).  
This phase temporarily requires a full-time commitment by 
the PI; for example, a summer semester might be an ideal 
time to start a program.  After initial set-up, the steady-
state operation of the overall program is most directly 
proportional to the number of advanced technical teams, 
which require the most input on behalf of the PI.  As a point 
of reference, approximately two advanced technical teams, 
properly and personally mentored by the PI, take the 
equivalent PI time investment as a full-time graduate 
student.  PI oversight of data source biocuration fluctuates 
as a function of project phase and especially the 
undergraduate quality control management experience.  
On average, eight fully trained and mentored curators 
require approximately the same PI time commitment as 
one full-time graduate student. 
 
RESULTS AND DISCUSSION 
We have developed our process using three different 
experimental disease models:  spinal cord injury (Mitchell 
and Lee, 2008), ALS (e.g., Mitchell and Lee, 2012; Irvin et 
al., 2015; Kim et al., 2015; Mitchell et al., 2015; Coan and 
Mitchell, 2015; Pfohl et al., 2015), and Alzheimer’s disease 
(Foley et al., 2015).  As part of our biocuration protocol and 
database development, we have utilized over 350 different 
undergraduate curators and 10 high school curators.  One 
of the major pros of an undergraduate biocuration program 
is that it is scalable.  We started with a team of three alpha 
curators.  We went through four major scale-ups, about 
one per year.  We currently maintain a total team of 50+ 
per semester, which includes about 30-40 primary curators 
and 15-20 tech team members and managers.  Based on 
our experience, to run and easily maintain a true curation 
assembly line with both curators and full-time quality 
control, at least eight students are necessary.  The addition 
of a couple of tech/IT teams and managers brings the 
minimum total for a “curation corporation” to be around 15 
students.  The maximum number of students is simply a 
function of student interest, physical and data resources, 
and of course PI/professor time. 
 
Case Study:  Clinical health informatics 
By curating ALS Clinic medical records, we developed a 
novel clinical ALS database, which consists of over 300 
different quantitative and qualitative measures, including 
pre-ALS health, ALS progression metrics, clinical 
treatments, diagnostic tests, and autopsy reports.  The pilot 
project included 300 patients, and the completed database 
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includes an astounding 1,587 patients, the largest and 
most comprehensive ALS data set available to date.  Such 
databases make way for epidemiological studies of 
demographics, disease progression and treatment.  For 
example, our resultant comprehensive assessment of 
antecedent disease, which found that ALS patients have 
substantially less other disease compared to matched non-
ALS controls, has resulted in novel hypotheses regarding 
possible neuroprotective mechanisms (Mitchell et al., 
2015).  Other examples of published related tech team 
projects include the identification of novel autopsy 
pathological marker relationships (Coan and Mitchell, 
2015).  Currently, an additional five tech teams have 
ongoing projects utilizing the clinical ALS database. 
 
Case Study: Experimental model informatics 
Our largest database is our ALS transgenic mouse 
database, which curates quantitative data from 3,500+ 
articles and 35,000+ figure panels into ~50,000 different 
metrics and treatments assessed over 160,000 time points.  
Since the inception of tech teams a couple of years ago, 12 
ALS tech teams and two AD tech teams have published six 
peer-reviewed journal articles and eight conference 
proceedings to date.  Numerous other articles are in review 
or in preparation.  Examples of hypothesis-driven tech 
team projects include: meta-analysis examining the 
relationship between amyloid beta and mouse cognition 
(Foley et al., 2015) and sex-dependent progression 
patterns in SOD1 G93A mice (Pfohl et al., 2015).  
Examples of exploratory data science tech team projects 
include: informatics-based analysis of the SOD1 G93A field 
topics to develop a functional ontology (Kim et al., 2015) 
and assessing novel homeostatic instabilities in ALS 
metabolism (Irvin et al., 2015).  Finally, the curated 
products (i.e., the databases), themselves, are an 
invaluable researcher resource.  Our first release of the 
searchable SOD1 G93A ALS mouse figure database is 
available on our website: http://www.pathology-
dynamics.org.  Ongoing work continues. 
 
Undergraduate curators are productive 
Eager undergraduates are very productive.  Because 
curation consists of much more than copy and paste 
transcription, the required capacity and opportunity to learn 
about the topic being curated maintains interest.  The 
quantified productivity of biocuration obviously depends on 
the complexity of the data being curated.  As a reference, 
an undergraduate curator reading through paragraphs of 
unorganized dictated text from medical records of standard 
clinic visits can transcribe, on average, about 10 layouts 
per hour of about the size and complexity shown in Figure 
2 (ALS Clinical Informatics layout). 
     For an experimental data capture project, Table 1 
illustrates the curation rates for different levels of data 
capture from published primary experimental data articles 
(SOD1 G93A ALS mouse).  The actual rate of productivity 
varies by the amount and type of data in each article.  
Generally, capturing all qualitative and quantitative data 
from an article takes less than two hours. 
Undergraduate curators are accurate 
Our biocuration accuracy requirement is 97.5% and is 
based on published tolerance of error in similar projects by 
professional biocurators (Keseler et al., 2014; Wu et al., 
2014a; Wu et al., 2014b).  However, for our SOD1 G93A 
transgenic ALS mouse experimental database, which 
curates published in vivo and in vitro data, our actual 
accuracy (based on 4+ years of biocuration quality control 
calculations) is an astounding 98.8% with a per-semester 
standard deviation of 0.2%. 
     Of the average 1.2% of entries recognized by quality 
control as erroneous, only 10.5% are classified as “critical 
errors,” which meaningfully compromise the integrity of the 
data.  Thus, our effective accuracy is 99.9%.  Discounting 
the fact that the ALS clinical informatics database does not 
require reading quantitative values from graphs, the 
accuracy of biocuration in that database is very 
comparable. 
     Our average error rate of 1.2% is in line with other 
similar databases that employ professional curators.  For 
example, the Candida Genome Database (CGD) and the 
EcoCyc Escherichia Coli Database employ manual 
biocurators that are Ph.D. biologists.  The CGD has an 
overall error rate average of 1.82% (Keseler et al., 2014).  
The EcoCyc Escherichia coli database has an overall error 
rate average of 1.40% (Keseler et al., 2013).  Thus, 
utilizing a curation assembly line, undergraduates are very 
capable of doing professional quality biocuration. 
     Figure 3 shows the breakdown of error types for the 
SOD1 G93A ALS mouse database for full data capture 
(aggregated curation for levels, 1-4).  The largest 
percentage of errors is ontological labeling errors (the 
placement of tags to make finding data easier).  Labeling of 
ontological terms requires the most knowledge of the 
SOD1 G93A ALS pathophysiology.  Ontological labeling is 
also the only subjective or interpretative entry in the 
database.  Thus, it is not surprising that ontological labeling 
has the highest error rate.  Fortunately, ontological labeling 
errors do not in any way affect the integrity of the curated 
data, itself.  Partial data capture errors are the second-
most common error.  Finally, about 11% of all errors are 
estimation errors, which are quantitative interpretative 
errors from reading a graph.  Almost all critical errors, 
which affect data integrity, are the direct result of over- or 
under-estimation of quantitative values. 
 
Automation and Future Directions 
Recently, we have been utilizing automated ontological 
scripts to assign ontological tags established on the 
presence of certain key words in relevant fields.  Based on 
one semester of data, this method appears to be 
substantively reducing this error type.  To reduce partial 
data capture errors, we have also recently added 
automated field checks, which appear to be very effective 
in reminding curators to fill in required fields.  We are also 
in the process of testing freeware to estimate values in-
between tick marks on graphs embedded in pdf files.  
Finally, automation is also being employed to calculate 
productivity using computerized time stamps.  Our IT team  
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continues to pursue projects to enhance automation in the 
entire data path process, including curation, quality control, 
and analysis. 
 
Biocuration enhances career opportunities 
One of the major benefits of biocuration in comparison to 
more traditional undergraduate research opportunities is 
that it opens up research to a greater number of students 
with more varied skill and/or career desires.  Curation 
teaches basic data organization and analytical skills 
necessary for any career.  It also serves as an equalizer, 





Figure 2.  Example curation data entry layout from ALS clinical informatics project.  This is one of the four data entry layouts used as 
part of our ALS clinical informatics project.  The layout above shows some of the parametric and non-parametric data that is recorded 
during a standard ALS clinic patient visit.  Additional separate layouts (not shown) exist for cognitive testing, patient history (medical 
and family history, onset symptom timeline, diagnostic and genetic testing), and autopsy and pathological reports.  If no data was 
present in the medical record or survey for a particular field, the field is simply left blank.  Note that patient name and MRN fields are 
only shown for reference as to how data is obtained from data source; curated data is ultimately de-identified to protect patient privacy. 
 







Table 1.  Biocuration capture type descriptions and entry times for published experimental model (e.g., SOD1 G93A ALS mouse). 
 
 
hierarchy.  Technical teams favor students that intend to 
pursue graduate school, academia or research-focused 
jobs.  Management and IT tend to favor students headed 
into industry or project management.  Formal end-of-
semester forms are used to track the students’ 
undergraduate research and post-graduate career plans 
throughout their undergraduate tenure in the lab.  
Additionally, informal exit surveys are utilized to track post-
graduation positions and acceptance.  Based on this data 
for about 350 students, we have determined that a tenure 
of three or more semesters was analogous to a 0.4-point 
GPA boost in the very competitive biomedical engineering 
industry, including student co-op/internships and post-
graduation job offers.  A management position is 
analogous to 0.6-point GPA boost for biomedical industry, 
and about one-third of our multi-semester managers were 
offered industry project management positions.  To date, 
80% of students who authored a research publication or 
proceeding and applied to graduate school or professional 
school have been admitted. 
 
Conclusions 
Undergraduate biocuration can be successfully utilized to 
develop large, powerful databases and analyze 
corresponding informatics data.  Undergraduate 
biocurators using the assembly line curation method 
described have accuracy and productivity comparable to 
professional Ph.D. biocurators.  Moreover, biocuration 
provides invaluable research experience to a broader 
population of students who may not otherwise obtain a 
research position or hands-on experience.  Because of the 
breadth of positions involved in biocuration, it utilizes many 
different skill sets which are applicable to both research 
and industry jobs. 
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